Michael W Kattan

Michael W Kattan's AcademicInfluence.com Rankings

Michael W Kattan

Computer Science

#2984

World Rank

#3128

Historical Rank

Algorithms

#75

World Rank

#75

Historical Rank

Computational Linguistics

#92

World Rank

#94

Historical Rank

Machine Learning

#258

World Rank

#261

Historical Rank

computer-science Degrees

Download Badge

Computer Science

Why Is Michael W Kattan Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Michael W Kattan's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Assessing the Performance of Prediction Models: A Framework for Traditional and Novel Measures (2010) (3297)
Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update. (1997) (1884)
Comparison of 1,800 laparoscopic and open partial nephrectomies for single renal tumors. (2007) (1164)
Cancer control with radical prostatectomy alone in 1,000 consecutive patients. (2002) (987)
Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy. (2007) (868)
A Nomogram for Predicting the Likelihood of Additional Nodal Metastases in Breast Cancer Patients With a Positive Sentinel Node Biopsy (2003) (789)
Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer. (1999) (730)
A postoperative prognostic nomogram for renal cell carcinoma. (2001) (687)
Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. (2006) (675)
Prognostic model for predicting survival in men with hormone-refractory metastatic prostate cancer. (2003) (675)
Predicting 15-year prostate cancer specific mortality after radical prostatectomy. (2011) (600)
A 17-gene assay to predict prostate cancer aggressiveness in the context of Gleason grade heterogeneity, tumor multifocality, and biopsy undersampling. (2014) (584)
Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. (2005) (574)
Variations in lung cancer risk among smokers. (2003) (560)
Variations in morbidity after radical prostatectomy. (2002) (542)
Prognostic significance of positive surgical margins in radical prostatectomy specimens. (1995) (537)
Postoperative nomogram for 12-year sarcoma-specific death. (2002) (533)
Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy. (2004) (516)
Meta-analysis: Its strengths and limitations. (2008) (488)
A postoperative prognostic nomogram predicting recurrence for patients with conventional clear cell renal cell carcinoma. (2005) (475)
Factors predicting recovery of erections after radical prostatectomy. (2000) (474)
Defining biochemical recurrence of prostate cancer after radical prostatectomy: a proposal for a standardized definition. (2006) (473)
A Novel Urine Exosome Gene Expression Assay to Predict High-grade Prostate Cancer at Initial Biopsy. (2016) (430)
Prostate cancer-specific mortality after radical prostatectomy for patients treated in the prostate-specific antigen era. (2009) (430)
Correlation of proton MR spectroscopic imaging with gleason score based on step-section pathologic analysis after radical prostatectomy. (2005) (411)
Elevated levels of circulating interleukin-6 and transforming growth factor-beta1 in patients with metastatic prostatic carcinoma. (1999) (409)
An Individualized Risk Calculator for Research in Prodromal Psychosis. (2016) (403)
A preoperative nomogram identifying decreased risk of positive pelvic lymph nodes in patients with prostate cancer. (2003) (393)
Multicenter Comparison of Machine Learning Methods and Conventional Regression for Predicting Clinical Deterioration on the Wards (2016) (393)
Nomogram for overall survival of patients with progressive metastatic prostate cancer after castration. (2002) (389)
Postoperative nomogram for disease-specific survival after an R0 resection for gastric carcinoma. (2003) (386)
Androgen-independent prostate cancer progression in the TRAMP model. (1997) (382)
The surgical learning curve for prostate cancer control after radical prostatectomy. (2007) (380)
Counseling men with prostate cancer: a nomogram for predicting the presence of small, moderately differentiated, confined tumors. (2003) (364)
Elevated expression of caveolin is associated with prostate and breast cancer. (1998) (360)
Subtype Specific Prognostic Nomogram for Patients With Primary Liposarcoma of the Retroperitoneum, Extremity, or Trunk (2006) (360)
Prognostic Nomogram for Patients Undergoing Resection for Adenocarcinoma of the Pancreas (2004) (358)
Postoperative nomogram predicting risk of recurrence after radical cystectomy for bladder cancer. (2006) (358)
Variations among individual surgeons in the rate of positive surgical margins in radical prostatectomy specimens. (2003) (337)
Do margins matter? The prognostic significance of positive surgical margins in radical prostatectomy specimens. (2005) (331)
Pretreatment nomogram for predicting the outcome of three-dimensional conformal radiotherapy in prostate cancer. (2000) (318)
Prediction of indolent prostate cancer: validation and updating of a prognostic nomogram. (2006) (305)
Doctor, what are my chances of having a positive sentinel node? A validated nomogram for risk estimation. (2007) (270)
Prognostic impact of positive surgical margins in surgically treated prostate cancer: multi-institutional assessment of 5831 patients. (2005) (270)
Plasma levels of interleukin-6 and its soluble receptor are associated with prostate cancer progression and metastasis. (2001) (269)
Effect of papillary and chromophobe cell type on disease-free survival after nephrectomy for renal cell carcinoma (2006) (266)
Contemporary Update of a Multi-Institutional Predictive Nomogram for Salvage Radiotherapy After Radical Prostatectomy. (2016) (266)
Judging new markers by their ability to improve predictive accuracy. (2003) (265)
An updated catalog of prostate cancer predictive tools (2008) (260)
Comparison of Nomograms With Other Methods for Predicting Outcomes in Prostate Cancer: A Critical Analysis of the Literature (2008) (257)
Strategies for Handling Missing Data in Electronic Health Record Derived Data (2013) (256)
Outcome prediction in primary resected retroperitoneal soft tissue sarcoma: histology-specific overall survival and disease-free survival nomograms built on major sarcoma center data sets. (2013) (255)
Finasteride and high-grade prostate cancer in the Prostate Cancer Prevention Trial. (2007) (253)
Prediction of organ-confined prostate cancer: incremental value of MR imaging and MR spectroscopic imaging to staging nomograms. (2006) (248)
Predicting the presence and side of extracapsular extension: a nomogram for staging prostate cancer. (2004) (246)
Individualized prediction of colon cancer recurrence using a nomogram. (2008) (245)
Clinical and pathological significance of the level and extent of capsular invasion in clinical stage T1-2 prostate cancer. (1998) (242)
Prostate cancer – major changes in the American Joint Committee on Cancer eighth edition cancer staging manual (2017) (240)
Evaluation of a Nomogram used to predict the pathologic stage of clinically localized prostate carcinoma (1997) (238)
A preoperative prognostic nomogram for solid enhancing renal tumors 7 cm or less amenable to partial nephrectomy. (2007) (236)
American Joint Committee on Cancer acceptance criteria for inclusion of risk models for individualized prognosis in the practice of precision medicine (2016) (232)
Comparisons of nomograms and urologists' predictions in prostate cancer. (2002) (231)
Association of Metabolic Surgery With Major Adverse Cardiovascular Outcomes in Patients With Type 2 Diabetes and Obesity. (2019) (226)
Preoperative plasma levels of transforming growth factor beta(1) (TGF-beta(1)) strongly predict progression in patients undergoing radical prostatectomy. (2001) (225)
ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. (2014) (219)
Predicting Nonsentinel Node Status After Positive Sentinel Lymph Biopsy for Breast Cancer: Clinicians Versus Nomogram (2005) (213)
The addition of interleukin-6 soluble receptor and transforming growth factor beta1 improves a preoperative nomogram for predicting biochemical progression in patients with clinically localized prostate cancer. (2003) (212)
Systemic therapy in men with metastatic castration-resistant prostate cancer:American Society of Clinical Oncology and Cancer Care Ontario clinical practice guideline. (2014) (211)
Risk factors for complications and morbidity after radical retropubic prostatectomy. (1997) (208)
Urinary continence after radical retropubic prostatectomy: relationship with membranous urethral length on preoperative endorectal magnetic resonance imaging. (2002) (208)
Management of prostate cancer in older men: recommendations of a working group of the International Society of Geriatric Oncology (2010) (207)
Prostate cancer: incremental value of endorectal MR imaging findings for prediction of extracapsular extension. (2004) (207)
Pretreatment nomogram for predicting freedom from recurrence after permanent prostate brachytherapy in prostate cancer. (2001) (205)
International validation of a preoperative nomogram for prostate cancer recurrence after radical prostatectomy. (2002) (205)
Variations among high volume surgeons in the rate of complications after radical prostatectomy: further evidence that technique matters. (2005) (204)
Comparison of endorectal magnetic resonance imaging, guided prostate biopsy and digital rectal examination in the preoperative anatomical localization of prostate cancer. (2005) (204)
A catalog of prostate cancer nomograms. (2001) (204)
Prediction of response to salvage radiation therapy in patients with prostate cancer recurrence after radical prostatectomy. (2001) (201)
Eligibility and outcomes reporting guidelines for clinical trials for patients in the state of a rising prostate-specific antigen: recommendations from the Prostate-Specific Antigen Working Group. (2004) (201)
Distinguishing clinically important from unimportant prostate cancers before treatment: value of systematic biopsies. (1996) (199)
Prognostic nomogram for sunitinib in patients with metastatic renal cell carcinoma (2008) (195)
Management of prostate cancer in older patients: updated recommendations of a working group of the International Society of Geriatric Oncology. (2014) (192)
Prospectively packaged lymph node dissections with radical cystectomy: evaluation of node count variability and node mapping. (2004) (189)
Phenotypically directed multimodal therapy for chronic prostatitis/chronic pelvic pain syndrome: a prospective study using UPOINT. (2010) (186)
Monotherapy for stage T1-T2 prostate cancer: radical prostatectomy, external beam radiotherapy, or permanent seed implantation. (2004) (184)
Estimating a time‐dependent concordance index for survival prediction models with covariate dependent censoring (2013) (179)
Validation of Partin tables for predicting pathological stage of clinically localized prostate cancer. (2000) (179)
Development and validation of a nomogram predicting the outcome of prostate biopsy based on patient age, digital rectal examination and serum prostate specific antigen. (2005) (179)
Predicting quality of life after radical prostatectomy: results from CaPSURE. (2004) (179)
Transition zone prostate cancer: metabolic characteristics at 1H MR spectroscopic imaging--initial results. (2003) (178)
Nomogram Predicting Prostate Cancer-specific Mortality for Men with Biochemical Recurrence After Radical Prostatectomy. (2015) (178)
Location, extent and number of positive surgical margins do not improve accuracy of predicting prostate cancer recurrence after radical prostatectomy. (2009) (178)
Predicting an optimal outcome after radical prostatectomy: the trifecta nomogram. (2008) (178)
The utility of magnetic resonance imaging and spectroscopy for predicting insignificant prostate cancer: an initial analysis (2007) (177)
Assessing the incremental value of diagnostic and prognostic markers: a review and illustration (2012) (177)
Validation and adaptation of a nomogram for predicting the survival of patients with extremity soft tissue sarcoma using a three‐grade system (2005) (177)
Association of Pre- and Postoperative Plasma Levels of Transforming Growth Factor β1 and Interleukin 6 and Its Soluble Receptor with Prostate Cancer Progression (2004) (177)
Prostate cancer: detection of extracapsular extension by genitourinary and general body radiologists at MR imaging. (2004) (177)
High expression of the Met receptor in prostate cancer metastasis to bone. (2002) (176)
Retroperitoneal lymph node dissection for nonseminomatous germ cell testicular cancer: impact of patient selection factors on outcome. (2005) (174)
Integration of gene expression profiling and clinical variables to predict prostate carcinoma recurrence after radical prostatectomy (2005) (173)
Assessing individual risk for prostate cancer. (2007) (172)
A genomic classifier improves prediction of metastatic disease within 5 years after surgery in node-negative high-risk prostate cancer patients managed by radical prostatectomy without adjuvant therapy. (2015) (170)
Pattern of prostate-specific antigen (PSA) failure dictates the probability of a positive bone scan in patients with an increasing PSA after radical prostatectomy. (2005) (166)
Critical review of prostate cancer predictive tools. (2009) (166)
Pretreatment nomogram that predicts 5-year probability of metastasis following three-dimensional conformal radiation therapy for localized prostate cancer. (2003) (165)
A Nomogram for Predicting Disease-specific Survival After Hepatic Resection for Metastatic Colorectal Cancer (2008) (164)
Nomograms are superior to staging and risk grouping systems for identifying high-risk patients: preoperative application in prostate cancer (2003) (163)
The Impact of Cross-National Carriers of Business Ethics on Attitudes about Questionable Practices and Form of Moral Reasoning (1996) (160)
Association of preoperative plasma levels of insulin-like growth factor I and insulin-like growth factor binding proteins-2 and -3 with prostate cancer invasion, progression, and metastasis. (2002) (153)
Comparison of Cox regression with other methods for determining prediction models and nomograms. (2003) (153)
Testosterone as a predictor of pathological stage in clinically localized prostate cancer. (2005) (149)
Incidence of benign lesions for clinically localized renal masses smaller than 7 cm in radiological diameter: influence of sex. (2006) (148)
Nomograms for Visualization of Naive Bayesian Classifier (2004) (147)
Decipher Genomic Classifier Measured on Prostate Biopsy Predicts Metastasis Risk. (2016) (145)
Partial nephrectomy for renal cortical tumors: pathologic findings and impact on outcome. (2002) (144)
Nomogram predictive of pathological inguinal lymph node involvement in patients with squamous cell carcinoma of the penis. (2006) (144)
Prediction of seminal vesicle invasion in prostate cancer: incremental value of adding endorectal MR imaging to the Kattan nomogram. (2007) (144)
Long-term outcome among men with conservatively treated localised prostate cancer (2006) (143)
Multicenter analysis of effect of high biologic effective dose on biochemical failure and survival outcomes in patients with Gleason score 7-10 prostate cancer treated with permanent prostate brachytherapy. (2009) (141)
Individualizing Risk Prediction for Positive Coronavirus Disease 2019 Testing (2020) (141)
Development and validation of nomograms to provide individualised predictions of seizure outcomes after epilepsy surgery: a retrospective analysis (2015) (140)
A nomogram to predict seminal vesicle invasion by the extent and location of cancer in systematic biopsy results. (2003) (140)
Validation of the postoperative nomogram for 12‐year sarcoma‐specific mortality (2004) (139)
The role of preoperative endorectal magnetic resonance imaging in the decision regarding whether to preserve or resect neurovascular bundles during radical retropubic prostatectomy (2004) (137)
Surgeon experience is strongly associated with biochemical recurrence after radical prostatectomy for all preoperative risk categories. (2008) (137)
Predicting patient discharge disposition after total joint arthroplasty in the United States. (2010) (136)
Hazard rates for progression after radical prostatectomy for clinically localized prostate cancer. (1997) (135)
A comprehensive data level analysis for cancer diagnosis on imbalanced data (2019) (135)
Predicting survival after curative colectomy for cancer: individualizing colon cancer staging. (2011) (134)
Survival among men with clinically localized prostate cancer treated with radical prostatectomy or radiation therapy in the prostate specific antigen era. (2012) (134)
The comparability of models for predicting the risk of a positive prostate biopsy with prostate-specific antigen alone: a systematic review. (2008) (133)
Ten-Year Outcomes and Risk Factors After Anterior Cruciate Ligament Reconstruction: A MOON Longitudinal Prospective Cohort Study (2018) (133)
Predictive and prognostic models in radical prostatectomy candidates: a critical analysis of the literature. (2010) (132)
Management of prostate‐specific antigen relapse in prostate cancer: A European consensus (2004) (130)
Ki-67 and outcome in clinically localised prostate cancer: analysis of conservatively treated prostate cancer patients from the Trans-Atlantic Prostate Group study (2009) (130)
Drawing Nomograms with R: applications to categorical outcome and survival data. (2017) (128)
A Nomogram That Predicts the Presence of Sentinel Node Metastasis in Melanoma With Better Discrimination Than the American Joint Committee on CancerStaging System (2005) (127)
Nomograms for Predicting the Risk of Arm Lymphedema after Axillary Dissection in Breast Cancer (2011) (127)
Achieving optimal outcomes after radical prostatectomy. (2005) (126)
Prostate Specific Antigen Working Group guidelines on prostate specific antigen doubling time. (2008) (126)
A critical appraisal of logistic regression‐based nomograms, artificial neural networks, classification and regression‐tree models, look‐up tables and risk‐group stratification models for prostate cancer (2007) (122)
A nomogram for individualized estimation of survival among patients with brain metastasis. (2012) (122)
Preoperative nomogram predicting 12-year probability of metastatic renal cancer. (2008) (121)
The risk of developing coronary artery disease or congestive heart failure, and overall mortality, in type 2 diabetic patients receiving rosiglitazone, pioglitazone, metformin, or sulfonylureas: a retrospective analysis (2009) (121)
Assessment of a Person-Level Risk Calculator to Predict New-Onset Bipolar Spectrum Disorder in Youth at Familial Risk (2017) (120)
Transatlantic Consensus Group on active surveillance and focal therapy for prostate cancer (2012) (120)
A novel prognostic nomogram is more accurate than conventional staging systems for predicting survival after resection of hepatocellular carcinoma. (2008) (120)
E-cadherin immunostaining of bladder transitional cell carcinoma, carcinoma in situ and lymph node metastases with long-term followup. (2001) (119)
Validation of a postresection pancreatic adenocarcinoma nomogram for disease-specific survival. (2005) (119)
Machine Learning for Survival Analysis: A Case Study on Recurrence of Prostate Cancer (1999) (119)
Validation of the Kattan preoperative nomogram for prostate cancer recurrence using a community based cohort: results from cancer of the prostate strategic urological research endeavor (capsure). (2004) (118)
Background for the proposal of SIOG guidelines for the management of prostate cancer in senior adults. (2010) (118)
Urinary PCA3 as a predictor of prostate cancer in a cohort of 3,073 men undergoing initial prostate biopsy. (2014) (118)
Encyclopedia of medical decision making (2009) (118)
Evaluating a New Marker’s Predictive Contribution (2004) (117)
Prognostic significance of the diameter of perineural invasion in radical prostatectomy specimens. (2001) (116)
Prevalence and recognition of obesity and its associated comorbidities: cross-sectional analysis of electronic health record data from a large US integrated health system (2017) (116)
Improved prediction of prostate cancer recurrence through systems pathology. (2007) (116)
Development of a nomogram that predicts the probability of a positive prostate biopsy in men with an abnormal digital rectal examination and a prostate-specific antigen between 0 and 4 ng/mL. (1999) (115)
Determining the Area under the ROC Curve for a Binary Diagnostic Test (2000) (115)
Nomogram predictive of cancer specific survival in patients undergoing partial or total amputation for squamous cell carcinoma of the penis. (2006) (113)
Preoperative nomograms incorporating magnetic resonance imaging and spectroscopy for prediction of insignificant prostate cancer (2012) (113)
Clinical characteristics, complications, comorbidities and treatment patterns among patients with type 2 diabetes mellitus in a large integrated health system (2015) (112)
Multifocal renal cortical tumors: frequency, associated clinicopathological features and impact on survival. (2004) (108)
Transforming growth factor-β1: Comparative immunohistochemical localization in human primary and metastatic prostate cancer (1995) (107)
A competing‐risks nomogram for sarcoma‐specific death following local recurrence (2003) (102)
The learning curve for surgical margins after open radical prostatectomy: implications for margin status as an oncological end point. (2010) (101)
A critique of the decision analysis for clinically localized prostate cancer. (1994) (101)
Importance of prostate volume in the European Randomised Study of Screening for Prostate Cancer (ERSPC) risk calculators: results from the prostate biopsy collaborative group (2011) (101)
Nomograms for preoperative prediction of prognosis in patients with oral cavity squamous cell carcinoma (2014) (100)
Radical prostatectomy in men aged ≥70 years: effect of age on upgrading, upstaging, and the accuracy of a preoperative nomogram (2008) (99)
Effects of pathologic stage on the learning curve for radical prostatectomy: evidence that recurrence in organ-confined cancer is largely related to inadequate surgical technique. (2008) (99)
Efficacy and safety of single-agent pertuzumab (rhuMAb 2C4), a human epidermal growth factor receptor dimerization inhibitor, in castration-resistant prostate cancer after progression from taxane-based therapy. (2007) (99)
Increase in overall mortality risk in patients with type 2 diabetes receiving glipizide, glyburide or glimepiride monotherapy versus metformin: a retrospective analysis (2012) (98)
Combined endorectal and phased-array MRI in the prediction of pelvic lymph node metastasis in prostate cancer. (2006) (97)
Customized dose prescription for permanent prostate brachytherapy: insights from a multicenter analysis of dosimetry outcomes. (2007) (96)
A calcitriol analogue, EB1089, inhibits the growth of LNCaP tumors in nude mice. (2000) (95)
Prostate-specific antigen (PSA) and PSA density: racial differences in men without prostate cancer. (1997) (95)
Predicting life expectancy in men with clinically localized prostate cancer. (2006) (95)
Preoperative plasma levels of transforming growth factor β1 strongly predict clinical outcome in patients with bladder carcinoma (2001) (94)
Bladder cancer as a prognostic factor for upper tract transitional cell carcinoma. (2004) (94)
Method for evaluating prediction models that apply the results of randomized trials to individual patients (2007) (94)
Development and validation of a model for individualized prediction of hospitalization risk in 4,536 patients with COVID-19 (2020) (93)
The Relationship between Prostate-Specific Antigen and Prostate Cancer Risk: The Prostate Biopsy Collaborative Group (2010) (92)
Prospective multi-institutional study evaluating the performance of prostate cancer risk calculators. (2011) (91)
Primary human prostate cancer cells harboring p53 mutations are clonally expanded in metastases. (1997) (91)
Prostate cancer nomograms: an update. (2006) (91)
Initial biopsy outcome prediction--head-to-head comparison of a logistic regression-based nomogram versus artificial neural network. (2007) (89)
A closed testing procedure to select an appropriate method for updating prediction models (2017) (89)
Predicting Individual Survival After Gastric Cancer Resection: Validation of a U.S.-Derived Nomogram at a Single High-Volume Center in Europe (2006) (88)
Inventory of prostate cancer predictive tools (2008) (88)
Validation of a nomogram for predicting disease‐specific survival after an R0 resection for gastric carcinoma (2005) (88)
Prognostic models and algorithms in renal cell carcinoma. (2008) (88)
Lymphovascular invasion as a predictor of disease progression in prostate cancer. (2000) (87)
Preoperative Anemia and Perioperative Outcomes in Patients Who Undergo Elective Spine Surgery (2013) (86)
An independently validated nomogram for individualized estimation of survival among patients with newly diagnosed glioblastoma: NRG Oncology RTOG 0525 and 0825. (2016) (86)
Prognostic nomogram for renal insufficiency after radical or partial nephrectomy. (2005) (86)
The c‐index is not proper for the evaluation of t‐year predicted risks (2019) (86)
The Risk of Overall Mortality in Patients With Type 2 Diabetes Receiving Glipizide, Glyburide, or Glimepiride Monotherapy (2010) (85)
Markers and meaning of primary treatment failure. (2003) (85)
Impact of a clinical pathway for radical retropubic prostatectomy. (1998) (84)
Nomograms for prostate cancer (2006) (83)
Nomograms as predictive models. (2002) (82)
Guidelines for reporting of statistics for clinical research in urology (2019) (82)
A validation of two preoperative nomograms predicting recurrence following radical prostatectomy in a cohort of European men. (2002) (82)
Validation of a nomogram for predicting positive repeat biopsy for prostate cancer. (2005) (82)
A Contemporary Prostate Biopsy Risk Calculator Based on Multiple Heterogeneous Cohorts. (2018) (80)
An exploratory analysis of alkaline phosphatase, lactate dehydrogenase, and prostate-specific antigen dynamics in the phase 3 ALSYMPCA trial with radium-223 (2017) (80)
Do margins matter? The influence of positive surgical margins on prostate cancer-specific mortality. (2014) (79)
Validation Study of the Accuracy of a Postoperative Nomogram for Recurrence After Radical Prostatectomy for Localized Prostate Cancer (2002) (78)
The definition of biochemical failure in patients treated with definitive radiotherapy. (2000) (77)
Erectile and urinary dysfunction after radical prostatectomy for prostate cancer in Quebec: a population-based study of 2415 men. (2004) (77)
Gleason Upgrading with Time in a Large Prostate Cancer Active Surveillance Cohort. (2015) (77)
Mortality after prostate cancer treatment with radical prostatectomy, external-beam radiation therapy, or brachytherapy in men without comorbidity. (2013) (76)
Comparison of immunohistochemistry with reverse transcription-PCR for the detection of micrometastatic prostate cancer in lymph nodes. (2003) (75)
Nomogram incorporating PSA level to predict cancer‐specific survival for men with clinically localized prostate cancer managed without curative intent (2008) (75)
The Danger of Applying Group-level Utilities in Decision Analyses of the Treatment of Localized Prostate Cancer in Individual Patients (1998) (74)
Experiments to determine whether recursive partitioning (CART) or an artificial neural network overcomes theoretical limitations of Cox proportional hazards regression. (1998) (74)
Validation of pretreatment nomograms for predicting indolent prostate cancer: efficacy in contemporary urological practice. (2008) (73)
Preoperative and postoperative nomograms incorporating surgeon experience for clinically localized prostate cancer (2009) (73)
Nomogram use for the prediction of indolent prostate cancer (2007) (73)
Use of nomograms to predict the risk of disease recurrence after definitive local therapy for prostate cancer. (2003) (72)
Implementing a Scientifically Valid, Cost-Effective, and Scalable Data Collection System at Point of Care: The Cleveland Clinic OME Cohort (2019) (71)
Pretreatment nomogram predicting ten-year biochemical outcome of three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for prostate cancer. (2007) (70)
Assessment of the biologic markers p53, ki‐67, and apoptotic index as predictive indicators of prostate carcinoma recurrence after surgery (1998) (69)
Evaluating the PCPT risk calculator in ten international biopsy cohorts: results from the Prostate Biopsy Collaborative Group (2012) (69)
The index of prediction accuracy: an intuitive measure useful for evaluating risk prediction models (2018) (69)
Efficacy of growth factors compared to other therapies for low‐risk myelodysplastic syndromes (2007) (68)
Extracting and utilizing electronic health data from Epic for research. (2018) (68)
What is a real nomogram? (2010) (67)
A Decision Analysis for Treatment of Clinically Localized Prostate Cancer (1997) (67)
Bladder neck involvement in pathological stage pT4 radical prostatectomy specimens is not an independent prognostic factor. (2002) (67)
Pathological features and prognostic significance of prostate cancer in the apical section determined by whole mount histology. (1999) (66)
A Model for Predicting the Risk of De Novo Stress Urinary Incontinence in Women Undergoing Pelvic Organ Prolapse Surgery (2014) (65)
Guidelines for Reporting of Statistics for Clinical Research in Urology. (2019) (65)
Body mass index is weakly associated with, and not a helpful predictor of, disease progression in men with clinically localized prostate carcinoma treated with radical prostatectomy (2005) (65)
An Externally Validated Model for Predicting Long-Term Survival after Exercise Treadmill Testing in Patients with Suspected Coronary Artery Disease and a Normal Electrocardiogram (2007) (64)
A nomogram for predicting upgrading in patients with low‐ and intermediate‐grade prostate cancer in the era of extended prostate sampling (2010) (64)
Prostate cancer nomograms and prognostic models: Introduction (2002) (63)
Validating a prognostic model (2006) (63)
Postatrophic hyperplasia of the prostate: lack of association with prostate cancer. (1999) (63)
Long-term follow-up of bilateral sporadic renal tumors. (2003) (63)
Recall and attitudes in patients with prostate cancer. (1999) (62)
An independently validated nomogram for individualized estimation of survival among patients with newly diagnosed glioblastoma: NRG Oncology RTOG 0525 and 0825 (2016) (62)
Clinical Inertia in Type 2 Diabetes Management: Evidence From a Large, Real-World Data Set (2018) (62)
Development and validation of a 32-gene prognostic index for prostate cancer progression (2013) (62)
Radical prostatectomy for carcinoma of the prostate (2004) (61)
Prediction of progression: nomograms of clinical utility. (2002) (61)
Multifocal high grade prostatic intraepithelial neoplasia is a risk factor for subsequent prostate cancer. (2010) (61)
Importance of implant dosimetry for patients undergoing prostate brachytherapy. (2003) (60)
Postoperative nomogram predicting the 9-year probability of prostate cancer recurrence after permanent prostate brachytherapy using radiation dose as a prognostic variable. (2010) (60)
Assessment of the biologic markers p53, Ki-67, and apoptotic index as predictive indicators of prostate carcinoma recurrence after surgery. (1998) (60)
Evaluation of neoadjuvant therapy and histopathologic response in primary, high‐grade retroperitoneal sarcomas using the sarcoma nomogram (2010) (60)
A nomogram for predicting a positive repeat prostate biopsy in patients with a previous negative biopsy session. (2009) (59)
Screening for prostate cancer. (1995) (59)
Calibration plots for risk prediction models in the presence of competing risks (2014) (59)
Nomograms. Introduction. (2002) (58)
Validation study of the accuracy of a postoperative nomogram for recurrence after radical prostatectomy for localized prostate cancer. (2002) (58)
Predicting risk of pelvic floor disorders 12 and 20 years after delivery (2017) (58)
Nomogram for predicting 5-year disease-specific mortality after primary surgery for epithelial ovarian cancer. (2012) (58)
An exploratory analysis of alkaline phosphatase, lactate dehydrogenase, and prostate-specific antigen dynamics in the phase 3 ALSYMPCA trial with radium-223 (2017) (57)
Predicting outcomes in renal cell carcinoma (2005) (56)
Conditional Probability of Survival Nomogram for 1-, 2-, and 3-Year Survivors After an R0 Resection for Gastric Cancer (2013) (56)
Is intraoperative frozen section analysis an efficient way to reduce positive surgical margins? (2005) (56)
Nomogram for survival analysis in the presence of competing risks. (2017) (55)
Optimal definition of biochemical recurrence after radical prostatectomy depends on pathologic risk factors: identifying candidates for early salvage therapy. (2014) (54)
Racial and ethnic differences in preference-based health status measure* (2006) (54)
Detection of clinically significant, occult prostate cancer metastases in lymph nodes using a splice variant-specific rt-PCR assay for human glandular kallikrein. (2003) (54)
A predictive nomogram for recurrence of carcinoma of the major salivary glands. (2013) (54)
Risk assessment for biochemical recurrence prior to radical prostatectomy: Significant enhancement contributed by human glandular kallikrein 2 (hK2) and free prostate specific antigen (PSA) in men with moderate PSA‐elevation in serum (2006) (54)
Reasons for Discontinuing Active Surveillance: Assessment of 21 Centres in 12 Countries in the Movember GAP3 Consortium. (2019) (54)
Incidence, Location, and Significance of Periprostatic and Periseminal Vesicle Lymph Nodes in Prostate Cancer (2001) (54)
The effect of comorbidity and socioeconomic status on sexual and urinary function and on general health-related quality of life in men treated with radical prostatectomy for localized prostate cancer. (2008) (53)
Evidence for the usefulness of nomograms (2007) (53)
Intensification of Diabetes Therapy and Time Until A1C Goal Attainment Among Patients With Newly Diagnosed Type 2 Diabetes Who Fail Metformin Monotherapy Within a Large Integrated Health System (2016) (53)
The role of human glandular kallikrein 2 for prediction of pathologically organ confined prostate cancer (2003) (53)
ColoRectal Cancer Predicted Risk Online (CRC-PRO) Calculator Using Data from the Multi-Ethnic Cohort Study (2014) (53)
Effect of Smoking on the Perioperative Outcomes of Patients Who Undergo Elective Spine Surgery (2013) (52)
Cost-Effectiveness of Interferon- and Conventional Chemotherapy in Chronic Myelogenous Leukemia (1996) (52)
Postoperative Nomograms Predictive of Survival After Surgical Management of Malignant Tumors of the Major Salivary Glands (2014) (51)
Predicting 6-Year Mortality Risk in Patients With Type 2 Diabetes (2008) (51)
Clinicians versus nomogram: predicting future technetium-99m bone scan positivity in patients with rising prostate-specific antigen after radical prostatectomy for prostate cancer. (2013) (50)
Adjuvant weekly docetaxel for patients with high risk prostate cancer after radical prostatectomy: a multi-institutional pilot study. (2007) (50)
Optimizing outcomes and quality of life in the hormonal treatment of prostate cancer (2006) (50)
Comparative effectiveness of screening strategies for Lynch syndrome. (2015) (49)
Performance of prostate cancer prevention trial risk calculator in a contemporary cohort screened for prostate cancer and diagnosed by extended prostate biopsy. (2010) (49)
Free PSA isoforms and intact and cleaved forms of urokinase plasminogen activator receptor in serum improve selection of patients for prostate cancer biopsy (2007) (49)
Benchmarking lung cancer mortality rates in current and former smokers. (2004) (49)
Assessing quality of life in men with clinically localized prostate cancer: Development of a new instrument for use in multiple settings (2004) (48)
Paper Standard Gamble: The Reliability of a Paper Questionnaire to Assess Utility (2003) (48)
Statistical prediction models, artificial neural networks, and the sophism "I am a patient, not a statistic". (2002) (48)
Radical retropubic prostatectomy: limited benefit of autologous blood donation. (1995) (48)
Association of Bariatric Surgery With Cancer Risk and Mortality in Adults With Obesity. (2022) (47)
Quantitative immunohistochemical analysis of insulin-like growth factor binding protein-3 in human prostatic adenocarcinoma: a prognostic study. (1998) (47)
Androgen Deprivation Therapy in Men With Prostate Cancer Does Not Affect Risk of Infection With SARS-CoV-2. (2020) (47)
Major shifts in the treatment and prognosis of prostate cancer due to changes in pathological diagnosis and grading (2007) (47)
Adjuvant leuprolide with or without docetaxel in patients with high‐risk prostate cancer after radical prostatectomy (TAX‐3501) (2013) (47)
The Main Predictors of Length of Stay After Total Knee Arthroplasty: Patient-Related or Procedure-Related Risk Factors. (2019) (47)
Comparison of perioperative outcomes including severe bladder injury between monopolar and bipolar transurethral resection of bladder tumors: a population based comparison. (2014) (47)
Nomograms for predicting graft function and survival in living donor kidney transplantation based on the UNOS Registry. (2009) (47)
Assessment of the enhancement in predictive accuracy provided by systematic biopsy in predicting outcome for clinically localized prostate cancer. (2004) (47)
The association of community health indicators with outcomes for kidney transplant recipients in the United States. (2012) (47)
Development of improved nomogram for prediction of outcome of initial prostate biopsy using readily available clinical information. (2011) (46)
Utilities Should Not Be Multiplied: Evidence From the Preference-Based Scores in the United States (2008) (46)
Adenovirus-mediated suicide gene therapy for experimental bladder cancer. (1997) (46)
Pan-cancer prediction of radiotherapy benefit using genomic-adjusted radiation dose (GARD): a cohort-based pooled analysis. (2021) (46)
Is it time to tailor the prediction of radio-induced toxicity in prostate cancer patients? Building the first set of nomograms for late rectal syndrome. (2012) (46)
A tool for predicting breast carcinoma mortality in women who do not receive adjuvant therapy (2004) (46)
Nomograms for predicting survival and recurrence in patients with adenoid cystic carcinoma. An international collaborative study. (2015) (45)
Free and complexed prostate-specific antigen serum ratios to predict probability of primary prostate cancer and benign prostatic hyperplasia. (1996) (45)
Challenges in meta-analysis of randomized clinical trials for rare harmful cardiovascular events: the case of rosiglitazone. (2008) (45)
Levels of expression of p27KIP1 protein in human prostate and prostate cancer: an immunohistochemical analysis. (1999) (45)
Perineural invasion of prostate carcinoma cells is associated with reduced apoptotic index (1996) (45)
Nomogram for deciding adjuvant treatment after surgery for oral cavity squamous cell carcinoma (2008) (44)
A power series beta Weibull regression model for predicting breast carcinoma (2015) (44)
Preoperative blood reverse transcriptase-PCR assays for prostate-specific antigen and human glandular kallikrein for prediction of prostate cancer progression after radical prostatectomy. (2002) (44)
Nomogram for survival after primary surgery for bulky stage IIIC ovarian carcinoma. (2008) (44)
Nomogram for predicting 30-day all-cause mortality after transvenous pacemaker and defibrillator lead extraction. (2015) (44)
Age and PSA predict likelihood of organ-confined disease in men presenting with PSA less than 10 ng/mL: implications for screening. (2003) (44)
Early postoperative peripheral blood reverse transcription PCR assay for prostate-specific antigen is associated with prostate cancer progression in patients undergoing radical prostatectomy. (2003) (43)
Seizure freedom score: A new simple method to predict success of epilepsy surgery (2015) (43)
Postoperative Nomogram for Predicting Cancer-Specific Mortality in Medullary Thyroid Cancer (2015) (43)
Are biochemical recurrence outcomes similar after radical prostatectomy and radiation therapy? Analysis of prostate cancer-specific mortality by nomogram-predicted risks of biochemical recurrence. (2015) (43)
Beyond prostate-specific antigen: new serologic biomarkers for improved diagnosis and management of prostate cancer. (2004) (42)
Complete resection of seminal vesicles at radical prostatectomy results in substantial long-term disease-free survival: multi-institutional study of 6740 patients. (2005) (42)
p53 immunochemistry is an independent prognostic marker for outcome in conservatively treated prostate cancer (2009) (42)
Correlation of preoperative plasma IGF-I levels with pathologic parameters and progression in patients undergoing radical prostatectomy. (2000) (41)
Unmet needs in the prediction and detection of metastases in prostate cancer. (2013) (41)
The impact of tumour location on the histological subtype of renal cortical tumours (2006) (41)
Defining high risk prostate cancer with risk groups and nomograms: implications for designing clinical trials. (2006) (41)
Prognostic importance of emerging cardiac, inflammatory, and renal biomarkers in chronic heart failure patients with reduced ejection fraction and anaemia: RED‐HF study (2017) (40)
A Nomogram For Predicting a Positive Repeat Prostate Biopsy in Patients With a Previous Negative Biopsy Session (2003) (40)
Association of free‐prostate specific antigen subfractions and human glandular kallikrein 2 with volume of benign and malignant prostatic tissue (2005) (40)
Predicting 10-Year Risk of End-Organ Complications of Type 2 Diabetes With and Without Metabolic Surgery: A Machine Learning Approach (2020) (40)
Percent free prostate specific antigen is not an independent predictor of organ confinement or prostate specific antigen recurrence in unscreened patients with localized prostate cancer treated with radical prostatectomy. (2002) (39)
Salvage Radiation Therapy Dose Response for Biochemical Failure of Prostate Cancer After Prostatectomy-A Multi-Institutional Observational Study. (2016) (39)
Magnetic resonance imaging in the prediction of biochemical recurrence of prostate cancer after radical prostatectomy (2009) (39)
Predicting clinical end points: treatment nomograms in prostate cancer. (2003) (38)
Radical prostatectomy nomograms in black American men: accuracy and applicability. (2003) (38)
Development and Validation of a Clinical Prognostic Stage Group System for Nonmetastatic Prostate Cancer Using Disease-Specific Mortality Results From the International Staging Collaboration for Cancer of the Prostate. (2020) (38)
Nomograms to predict naming decline after temporal lobe surgery in adults with epilepsy (2018) (38)
Systematic review of statistical methods used in molecular marker studies in cancer (2008) (38)
New variants at 10q26 and 15q21 are associated with aggressive prostate cancer in a genome-wide association study from a prostate biopsy screening cohort (2011) (37)
Detection of metastatic prostate cancer using a splice variant-specific reverse transcriptase-polymerase chain reaction assay for human glandular kallikrein. (2000) (36)
Derivation and validation of a machine learning risk score using biomarker and electronic patient data to predict progression of diabetic kidney disease (2021) (36)
Transforming growth factor-beta 1: comparative immunohistochemical localization in human primary and metastatic prostate cancer. (1995) (36)
When and how to use informatics tools in caring for urologic patients (2005) (36)
Prostate cancer diagnosed after repeat biopsies have a favorable pathological outcome but similar recurrence rate. (2006) (35)
Prediction of late-onset pouch failure in patients with restorative proctocolectomy with a nomogram. (2012) (35)
Nomogram for predicting malignancy in thyroid nodules using clinical, biochemical, ultrasonographic, and cytologic features. (2010) (35)
Preference Assessment Method Affects Decision-Analytic Recommendations: A Prostate Cancer Treatment Example (2004) (35)
Factors affecting the accuracy of prediction models limit the comparison of rival prediction models when applied to separate data sets. (2011) (35)
Clinical experience with intravenous estramustine phosphate, paclitaxel, and carboplatin in patients with castrate, metastatic prostate adenocarcinoma (2003) (35)
Evaluating the Prostate Cancer Prevention Trial High Grade prostate cancer risk calculator in 10 international biopsy cohorts: results from the prostate biopsy collaborative group (2014) (35)
Local progression among men with conservatively treated localized prostate cancer: results from the Transatlantic Prostate Group. (2008) (34)
An empirical approach to model selection through validation for censored survival data (2011) (34)
2131 DEVELOPMENT AND VALIDATION OF THE BIOPSY-BASED GENOMIC PROSTATE SCORE (GPS) AS A PREDICTOR OF HIGH GRADE OR EXTRACAPSULAR PROSTATE CANCER TO IMPROVE PATIENT SELECTION FOR ACTIVE SURVEILLANCE (2013) (34)
A measure of health-related quality of life among patients with localized prostate cancer: results from ongoing scale development. (2005) (34)
The log-beta Weibull regression model with application to predict recurrence of prostate cancer (2013) (34)
A national survey of attitudes regarding participation in prostate carcinoma testing (1996) (34)
Development and validation of a nomogram for predicting a positive repeat prostate biopsy in patients with a previous negative biopsy session in the era of extended prostate sampling (2010) (33)
Active surveillance for low-risk prostate cancer. (2013) (33)
PAPER STANDARD GAMBLE (2003) (33)
Conventional (clear cell) renal carcinoma metastases have greater bcl-2 expression than high-risk primary tumors. (2003) (32)
Patient Characteristics Associated With Severe Hypoglycemia in a Type 2 Diabetes Cohort in a Large, Integrated Health Care System From 2006 to 2015 (2018) (32)
Is year of radical prostatectomy a predictor of outcome in prostate cancer? (2004) (32)
The Wisdom of Crowds of Doctors (2016) (31)
Cross-cultural validation of the UCLA prostate cancer index. (2003) (31)
Evaluation of Preoperative Therapy for Pancreatic Cancer Using a Prognostic Nomogram (2006) (31)
Do margins matter? The prognostic significance of positive surgical margins in radical prostatectomy specimens. (2005) (31)
Gleason grade remains an important prognostic predictor in men diagnosed with prostate cancer while on finasteride therapy (2005) (31)
Anti-epidermal growth factor receptor monoclonal antibody cetuximab plus Doxorubicin in the treatment of metastatic castration-resistant prostate cancer. (2009) (30)
Predicting survival in women with breast cancer and brain metastasis (2012) (30)
Nomograms to predict patency after microsurgical vasectomy reversal. (2012) (29)
Robot-assisted versus other types of radical prostatectomy: Population-based safety and cost comparison in Japan, 2012–2013 (2014) (29)
Do impalpable stage T1c prostate cancers visible on ultrasound differ from those not visible? (2003) (29)
Herpes simplex virus based gene therapy enhances the efficacy of mitomycin C for the treatment of human bladder transitional cell carcinoma. (2004) (29)
Prognostic factors for survival in patients with hormone-refractory prostate cancer (HRPC) after initial androgen deprivation therapy (ADT). (2003) (29)
Ketorolac: safe and effective analgesia for the management of renal cortical tumors with partial nephrectomy. (2004) (29)
Effect of glycemic control on the Diabetes Complications Severity Index score and development of complications in people with newly diagnosed type 2 diabetes (2018) (29)
Defining the optimal treatment for clinical stage I nonseminomatous germ cell testicular cancer using decision analysis. (2010) (29)
Expert Systems in Medicine (2001) (28)
The Association Between Readmission and Patient Experience in a Total Hip Arthroplasty Population. (2017) (28)
The predictive accuracy of computer-based classification decision techniques.A review and research directions (1998) (28)
A simulation of factors affecting machine learning techniques: an examination of partitioning and class proportions (2000) (28)
Nomograms to predict isolated loco-regional or distant recurrence among women with uterine cancer. (2012) (28)
Development and internal validation of a nomogram predicting extracapsular extension in radical prostatectomy specimens (2010) (28)
Comparison of predictive accuracy for pathologically organ confined clinical stage T1c prostate cancer using human glandular kallikrein 2 and prostate specific antigen combined with clinical stage and Gleason grade. (2005) (28)
A Decision analysis to determine the appropriate treatment for low‐risk myelodysplastic syndromes (2007) (28)
Cardiovascular Outcomes in Patients With Type 2 Diabetes and Obesity: Comparison of Gastric Bypass, Sleeve Gastrectomy, and Usual Care (2021) (28)
Fifteen-year survival and recurrence rates after radiotherapy for localized prostate cancer. (1997) (28)
Nomograms for predicting changes in semen parameters in infertile men after varicocele repair. (2014) (28)
Artificial neural networks for medical classification decisions. (1995) (27)
How many lymphadenectomies does it take to cure one patient? (2008) (27)
Prostate cancer screening practices in a large, integrated health system: 2007–2014 (2017) (27)
The prognostic significance of Gleason Grade in patients treated with permanent prostate brachytherapy. (2003) (27)
High‐dose rate brachytherapy compared with open radical prostatectomy for the treatment of high‐risk prostate cancer: 10 year biochemical freedom from relapse (2012) (26)
A nomogram to predict the probability of passing the American Board of Internal Medicine examination (2012) (26)
Prediction Models for Postpartum Urinary and Fecal Incontinence in Primiparous Women (2013) (26)
Random forest swarm optimization-based for heart diseases diagnosis (2021) (26)
Cohort Studies: Design, Analysis, and Reporting. (2020) (26)
Antidiabetic treatment patterns and specialty care utilization among patients with type 2 diabetes and cardiovascular disease (2018) (25)
The risk of overall mortality in patients with Type 2 diabetes receiving different combinations of sulfonylureas and metformin: a retrospective analysis (2012) (25)
Association of Baseline Prostate-Specific Antigen Level With Long-term Diagnosis of Clinically Significant Prostate Cancer Among Patients Aged 55 to 60 Years (2020) (25)
Reduced penile size and treatment regret in men with recurrent prostate cancer after surgery, radiotherapy plus androgen deprivation, or radiotherapy alone. (2013) (25)
How to tell if a new marker improves prediction. (2011) (25)
Transitioning from a noon conference to an academic half-day curriculum model: effect on medical knowledge acquisition and learning satisfaction. (2014) (25)
ClearCode 34 : A Prognostic Risk Predictor for Localized Clear Cell Renal Cell Carcinoma (2014) (25)
Analysis of clinical stage T2 prostate cancer: do current subclassifications represent an improvement? (2002) (25)
The negative binomial–beta Weibull regression model to predict the cure of prostate cancer (2012) (25)
Validation of postoperative nomograms in prostate cancer patients with long-term follow-up. (2011) (25)
An improved prognostic model for stage T1a and T1b prostate cancer by assessments of cancer extent (2011) (25)
Clinical benefits of a multivariate prediction model for bladder cancer (2009) (25)
Protective heterologous T cell immunity in COVID-19 induced by the trivalent MMR and Tdap vaccine antigens (2021) (24)
Predicting the discharge status after liver transplantation at a single center: A new approach for a new era (2012) (24)
Statin use is associated with improved biochemical outcome after high-dose radiotherapy for clinically localized prostate cancer (2003) (23)
Predicting discharge to a long-term acute care hospital after admission to an intensive care unit. (2014) (23)
The association of selected pathological features with prostate cancer in a single-needle biopsy accession. (1998) (23)
Risk tolerance to MS therapies: Survey results from the NARCOMS registry. (2015) (23)
Cost-effectiveness of surgery for drug-resistant temporal lobe epilepsy in the US (2020) (23)
Postatrophic Hyperplasia of the Prostate (1999) (23)
Association of glucagon‐like peptide‐1 receptor agonist use and rates of acute myocardial infarction, stroke and overall mortality in patients with type 2 diabetes mellitus in a large integrated health system (2017) (23)
External validation of the TIMI risk score for secondary cardiovascular events among patients with recent myocardial infarction. (2018) (23)
The role of digital rectal examination, biopsy Gleason sum and prostate-specific antigen in selecting patients who require pelvic lymph node dissections for prostate cancer. (1996) (23)
Sarcoma nomogram: validation and a model to evaluate impact of therapy. (2007) (23)
Impact of the COVID-19 Pandemic on Healthcare Workers’ Risk of Infection and Outcomes in a Large, Integrated Health System (2020) (22)
A Comparison of Machine Learning with Human Judgment (1993) (22)
High radical prostatectomy surgical volume is related to lower radical prostatectomy total hospital charges. (2006) (21)
Validation of the Kattan Nomogram for Prostate Cancer Recurrence After Radical Prostatectomy. (2016) (21)
Prediction of morbidity and mortality in patients with type 2 diabetes (2013) (21)
Formalized prediction of clinically significant prostate cancer: is it possible? (2012) (21)
Current Recommendations for Delaying Renal Transplantation after Localized Prostate Cancer Treatment: Are They Still Appropriate? (2004) (21)
Nomogram to preoperatively predict the probability of requiring epididymovasostomy during vasectomy reversal. (2012) (21)
Development of a prostate cancer metagram (2009) (21)
Impact of unilateral interposition sural nerve grafting on recovery of urinary function after radical prostatectomy. (2004) (21)
The ‘CaP Calculator’: an online decision support tool for clinically localized prostate cancer (2010) (21)
Algorithms for prostate-specific antigen recurrence after treatment of localized prostate cancer. (2003) (21)
Development of nomogram to predict acute urinary retention or surgical intervention, with or without dutasteride therapy, in men with benign prostatic hyperplasia. (2006) (21)
How accurate are present risk group assignment tools in penile cancer? (2009) (21)
Cardiovascular comorbidity and treatment regret in men with recurrent prostate cancer (2012) (20)
Predicting seizure freedom after epilepsy surgery, a challenge in clinical practice (2019) (20)
Nomogram for selecting thyroid nodules for ultrasound‐guided fine‐needle aspiration biopsy based on a quantification of risk of malignancy (2013) (20)
Prostate-specific antigen doubling times are similar in patients with recurrence after radical prostatectomy or radiotherapy: a novel analysis. (1998) (20)
Long-term benefits of elective radiotherapy after prostatectomy for patients with positive surgical margins. (2006) (20)
Against Diagnosis (2008) (20)
How Much Weight Loss is Required for Cardiovascular Benefits? Insights From a Metabolic Surgery Matched-cohort Study. (2020) (19)
The Probability of A1C Goal Attainment in Patients With Uncontrolled Type 2 Diabetes in a Large Integrated Delivery System: A Prediction Model (2020) (19)
Twelve year outcomes following permanent brachytherapy in patients with clinically localized prostate cancer (2004) (19)
Are nomograms needed in the management of bladder cancer? (2010) (19)
Orange and Decisions-at-Hand: Bridging Predictive Data Mining and Decision Support (2001) (19)
Association of Weight Loss Achieved Through Metabolic Surgery With Risk and Severity of COVID-19 Infection. (2021) (19)
Patient responses to physician disclosures of industry conflicts of interest: A randomized field experiment (2019) (19)
Use of Nomograms for Personalized Decision-Analytic Recommendations (2010) (19)
Development and validation of preoperative nomogram for disease recurrence within 5 years after laparoscopic radical prostatectomy for prostate cancer. (2011) (19)
Pilot study of a utilities-based treatment decision intervention for prostate cancer patients. (2002) (18)
The association between race and treatment regret among men with recurrent prostate cancer (2014) (18)
Clinical Use of PCA3 and TMPRSS2:ERG Urinary Biomarkers in African-American Men Undergoing Prostate Biopsy. (2016) (18)
Incorporating predictions of individual patient risk in clinical trials. (2004) (18)
Prostate cancer: Personalized risk — stratified screening or abandoning it altogether? (2016) (18)
Cost-effectiveness of interferon-alpha and conventional chemotherapy in chronic myelogenous leukemia. (1996) (18)
Incorporation of postoperative CT data into clinical models to predict 5-year overall and recurrence free survival after primary cytoreductive surgery for advanced ovarian cancer. (2015) (17)
A comprehensive and novel predictive modeling technique using detailed pathology factors in men with localized prostate carcinoma (2002) (17)
External radiotherapy and permanent prostate brachytherapy in patients with localized prostate cancer. (2002) (17)
High PSA anxiety and low health literacy skills: drivers of early use of salvage ADT among men with biochemically recurrent prostate cancer after radiotherapy? (2015) (17)
Individualized Risk Estimation for Postoperative Complications After Surgery for Oral Cavity Cancer. (2015) (17)
Nomogram for survival after primary surgery for bulky stage IIIC ovarian carcinoma. (2006) (17)
Development of Nomograms to Predict the Recovery of Erectile Function Following Radical Prostatectomy. (2019) (16)
Gene based prediction of clinically localized prostate cancer progression after radical prostatectomy. (2010) (16)
Computer modeling in urology. (1996) (16)
Association Between Androgen Deprivation Therapy and Patient‐reported Depression in Men With Recurrent Prostate Cancer (2018) (16)
Improving the prediction of epilepsy surgery outcomes using basic scalp EEG findings (2021) (16)
Evaluation of peri-operative chemotherapy using a prognostic nomogram for survival after resection of colorectal liver metastases. (2009) (16)
How to judge a tumor marker (2005) (16)
Nomogram to aid selection of patients for short-stay thyroidectomy based on risk of postoperative hypocalcemia. (2011) (16)
Prognostic significance of race on biochemical control in patients with localized prostate cancer treated with permanent brachytherapy: multivariate and matched-pair analyses. (2001) (16)
Clinical stage T1c prostate cancer: Pathologic outcomes following radical prostatectomy in black and white men (2002) (16)
Immunohistochemistry for p16, but not Rb or p21, is an independent predictor of prognosis in conservatively treated, clinically localised prostate cancer (2010) (16)
Gender‐specific effects of oral hypoglycaemic agents on cancer risk in type 2 diabetes mellitus (2014) (16)
Models for Predicting Recurrence, Complications, and Health Status in Women After Pelvic Organ Prolapse Surgery. (2018) (16)
Comparative 5-year outcomes of brachytherapy and surgery for prostate cancer. (2011) (15)
Race is not a predictor of prostate cancer detection on repeat prostate biopsy. (2004) (15)
Development and validation of a pretreatment nomogram to predict overall survival in gastric cancer (2020) (15)
Naive Bayesian-Based Nomogram for Prediction of Prostate Cancer Recurrence (1999) (15)
Primer: using decision analysis to improve clinical decision making in urology (2006) (15)
Age and Prostate-Specific Antigen Level Prior to Diagnosis Predict Risk of Death from Prostate Cancer (2016) (15)
Nomogram to predict seminal vesicle invasion using the status of cancer at the base of the prostate on systematic biopsy (2010) (15)
The effect of race/ethnicity on the accuracy of the 2001 Partin Tables for predicting pathologic stage of localized prostate cancer. (2008) (15)
A Framework for the Evaluation of Statistical Prediction Models. (2020) (15)
Cost Effectiveness of 5-Alpha Reductase Inhibitors for the Prevention of Prostate Cancer in Multiple Patient Populations (2012) (15)
In vivo adenovirus-mediated suicide gene therapy of orthotopic bladder cancer. (2000) (15)
Impact of the COVID-19 pandemic on healthcare workers risk of infection and outcomes in a large, integrated health system. (2020) (14)
Validation of nomograms for overall survival, cancer‐specific survival, and recurrence in carcinoma of the major salivary glands (2018) (14)
Does mechanical bowel preparation improve quality of laparoscopic nephrectomy? Propensity score-matched analysis in Japanese series. (2013) (14)
The Use of Nomograms for Selecting BPH Candidates for Dutasteride Therapy. (2004) (14)
Nonlinear modeling was applied thoughtfully for risk prediction: the Prostate Biopsy Collaborative Group. (2015) (14)
Perioperative Outcome Comparisons Between Open and Laparoscopic Nephroureterectomy Among a Population-Based Cohort from 2010 to 2012. (2015) (14)
SHOULD I USE THIS NOMOGRAM? (2008) (14)
Does mechanical bowel preparation ameliorate damage from rectal injury in radical prostatectomy? Analysis of 151 rectal injury cases (2014) (14)
Using prostate‐specific antigen screening and nomograms to assess risk and predict outcomes in the management of prostate cancer (2006) (13)
PROSTATE CANCER-SPECIFIC MORTALITY AFTER RADICAL PROSTATECTOMY FOR PATIENTS TREATED IN THE PROSTATE- SPECIFIC ANTIGEN ERA (2008) (13)
A simulation model of colorectal cancer surveillance and recurrence (2014) (13)
Renal cell carcinoma: A nomogram for the CT imaging-inclusive prediction of indolent, non-clear cell renal cortical tumours. (2016) (13)
Guidelines for Reporting of Statistics for Clinical Research in Urology (2019) (13)
An empirical re-examination of the relationship among training, ability, and the acceptance of information technology (1991) (13)
Iodine-125 vs palladium-103 for low-risk prostate cancer: Preliminary urinary functional outcomes from a prospective randomized multicenter trial (2000) (13)
CLINICAL BENEFITS OF A MULTIVARIABLE PREDICTION MODEL FOR BLADDER CANCER: A DECISION ANALYTIC APPROACH (2008) (13)
Validating a Predictive Model for Presence of Additional Disease in the Non–Sentinel Lymph Nodes of a Woman with Sentinel Node Positive Breast Cancer (2007) (13)
Risk Factors for Loss to Follow-up in 3202 Patients at 2 Years After Anterior Cruciate Ligament Reconstruction: Implications for Identifying Health Disparities in the MOON Prospective Cohort Study (2019) (13)
Nomograms are difficult to beat. (2008) (13)
Temporal trends in percutaneous coronary intervention--associated acute cerebrovascular accident (from the 1998 to 2008 Nationwide Inpatient Sample Database). (2014) (12)
Differences in Biologic Utilization and Surgery Rates in Pediatric and Adult Crohn's Disease: Results From a Large Electronic Medical Record-derived Cohort. (2020) (12)
Prostate volume measured preoperatively predicts for organ-confined disease in men with clinically localized prostate cancer. (2007) (12)
Sequentially Updated Discharge Model for Optimizing Hospital Resource Use and Surgical Patients' Satisfaction. (2015) (12)
Changes in Characteristics and Treatment Patterns of Patients with Newly Diagnosed Type 2 Diabetes in a Large United States Integrated Health System between 2008 and 2013 (2016) (12)
Time trade-off utility modified to accommodate degenerative and life-threatening conditions (2001) (12)
Third international conference on innovations and challenges in prostate cancer: prevention, detection and treatment. (2003) (12)
Nomograms incorporating serum C‐reactive protein effectively predict mortality before and after surgical treatment of renal cell carcinoma (2015) (12)
Predicting Risk of Urinary Incontinence and Adverse Events After Midurethral Sling Surgery in Women (2016) (12)
Comparing treatment outcomes using utility assessment for health-related quality of life. (2003) (12)
Doc, what are my chances? A conversation about prognostic uncertainty. (2011) (12)
Predictive models for short- and long-term adverse outcomes following discharge in a contemporary population with acute coronary syndromes. (2013) (12)
Press Ganey Administration of Hospital Consumer Assessment of Healthcare Providers and Systems Survey Result in a Biased Responder Sample for Hip and Knee Arthroplasties. (2019) (11)
Validation of a Postoperative Nomogram Predicting Recurrence in Patients with Conventional Clear Cell Renal Cell Carcinoma. (2016) (11)
Testosterone replacement therapy and the risk of adverse cardiovascular outcomes and mortality (2019) (11)
PSA velocity and prostate cancer. (2004) (11)
Using the landmark method for creating prediction models in large datasets derived from electronic health records (2015) (11)
Generation of “Virtual” Control Groups for Single Arm Prostate Cancer Adjuvant Trials (2014) (11)
In‐hospital red blood cell distribution width change in patients with heart failure (2019) (11)
The Prognostic Value of Kidney Transplant Center Report Cards (2013) (11)
Validation of two preoperative Kattan nomograms predicting recurrence after radical prostatectomy for localized prostate cancer in Turkey: a multicenter study of the Uro-oncology Society. (2009) (11)
Comparative analysis of three risk assessment tools in Australian patients with prostate cancer (2011) (10)
Next-generation prostate cancer risk calculator for primary care physicians. (2017) (10)
Sural Nerve Interposition Grafting during Radical Prostatectomy. (2002) (10)
The prediction philosophy in statistics. (2008) (10)
Medical Risk Prediction (2021) (10)
Why can't nomograms be more like Netflix? (2010) (10)
Development and Validation of a Prognostic Nomogram for Progression-Free Survival in Patients with Advanced Renal Cell Carcinoma Treated with Pazopanib (2015) (10)
Impact of international variation of prostate cancer on a predictive nomogram for biochemical recurrence in clinically localised prostate cancer (2013) (10)
Re: Updated nomogram to predict pathologic stage of prostate cancer given prostate-specific antigen level, clinical stage, and biopsy gleason score (Partin Tables) based on cases from 2000 to 2005. (2007) (10)
Nomograms to Predict Verbal Memory Decline After Temporal Lobe Resection in Adults With Epilepsy (2021) (10)
PREOPERATIVE NOMOGRAM TO PREDICT POSITIVE LYMPH NODES DURING NEPHRECTOMY FOR RENAL CELL CARCINOMA (2008) (10)
Recent advances in evaluating the prognostic value of a marker (2010) (9)
A chronological database to support outcomes research in prostate cancer. (2003) (9)
Telephone interviews vs. workstation sessions for acquiring quality of life data (1999) (9)
Re‐calibration and external validation of an existing nomogram to predict aggressive recurrences after radical prostatectomy (2009) (9)
[Can nomograms derived in the U.S. applied to German patients? A study about the validation of preoperative nomograms predicting the risk of recurrence after radical prostatectomy]. (2003) (9)
Developing a Clinical Prediction Score: Comparing Prediction Accuracy of Integer Scores to Statistical Regression Models. (2021) (9)
SIOG (International Society of Geriatric Oncology) prostate cancer guidelines proposals in senior adult men (2007) (9)
Statistical Analysis and Reporting Guidelines for CHEST. (2020) (9)
Cost effectiveness of chemoprevention for prostate cancer with dutasteride in a high-risk population based on results from the REDUCE Clinical trial (2011) (9)
Performance comparisons in major uro‐oncological surgeries between the USA and Japan (2014) (9)
Prostate Cancer Postoperative Nomogram Scores and Obesity (2011) (9)
Measurements of cancer extent in a conservatively treated prostate cancer biopsy cohort (2010) (9)
Computer modeling of prostate cancer treatment. A paradigm for oncologic management? (1995) (9)
Tutorial: development of an online risk calculator platform. (2018) (8)
A nomogram for predicting 10-year life expectancy in men with prostate cancer after definitive therapy (2008) (8)
Editorial comment on: development, validation, and head-to-head comparison of logistic regression-based nomograms and artificial neural network models predicting prostate cancer on initial extended biopsy. (2008) (8)
Risk grouping versus risk continuum in patients with clinically localized prostate cancer: a taxometric test. (2010) (8)
Human kallikrein-2 gene and protein expression predicts prostate cancer at repeat biopsy (2014) (8)
Comparative Effectiveness: A Table of Expected Benefits and Harms (2009) (8)
Measuring hot flashes in men treated with hormone ablation therapy: an unmet need. (2006) (8)
Personalizing Radiotherapy Prescription Dose Using Genomic Markers of Radiosensitivity and Normal Tissue Toxicity in Non-Small Cell Lung Cancer. (2019) (8)
Outcomes of resections that spare vs remove an MRI‐normal hippocampus (2020) (8)
Current and Emerging Multianalyte Assays with Algorithmic Analyses-Are Laboratories Ready for Clinical Adoption? (2018) (8)
External validation of preoperative nomograms predicting biochemical recurrence after radical prostatectomy. (2013) (8)
A Nomogram Derived by Combination of Demographic and Biomarker Data Improves the Noninvasive Evaluation of Patients at Risk for Bladder Cancer (2016) (8)
Prediction tools in surgical oncology. (2012) (8)
Predicting Current Glycated Hemoglobin Values in Adults: Development of an Algorithm From the Electronic Health Record (2018) (8)
Explaining information technology use with the usefulness scale: a comparison with user age. (1994) (8)
Hidden Selection Bias Deriving From Donor Organ Characteristics Does Not Affect Performance Evaluations of Kidney Transplant Centers (2010) (8)
THE BENEFIT OF SHORT-TERM WEIGHT LOSS WITH ANTI-OBESITY MEDICATIONS IN REAL-WORLD CLINICAL PRACTICE. (2019) (7)
Factors affecting choice between ureterostomy, ileal conduit and continent reservoir after radical cystectomy: Japanese series (2014) (7)
Classification and regression trees versus nomograms: a bone scan positivity example. (2010) (7)
Monotherapy for stage T1/T2 prostate cancer: radical prostatectomy, external beam radiotherapy, or permanent prostate brachytherapy (2002) (7)
Development of a Nomogram Model Predicting Current Bone Scan Positivity in Patients Treated with Androgen-Deprivation Therapy for Prostate Cancer (2014) (7)
Do we need more nomograms for predicting outcomes in patients with prostate cancer? (2008) (7)
796: Surgeon Volume is Predictor of Improved Outcomes in Radical Prostatectomy Patients (2004) (7)
Risk Models for Individualized Prognosis in the Practice of Precision Oncology (2017) (7)
Applying a Neural Network to Prostate Cancer Survival Data (1997) (7)
A chronological database as backbone for clinical practice and research data management (2003) (7)
Development and Validation of a Prediction Model for Early Diagnosis of SCN1A-Related Epilepsies (2022) (7)
Comparison of two ordinal prediction models: A cancer staging system example (2015) (7)
COVID-19 Home Monitoring After Diagnosis and Health Care Utilization in an Integrated Health System (2021) (7)
Training, ability, and the acceptance of information technology: an empirical study of IS personnel and end users (1991) (7)
Larissa Heart Failure Risk Score: a proposed simple score for risk stratification in chronic heart failure (2018) (7)
Association between shared medical appointments and weight loss outcomes and anti‐obesity medication use in patients with obesity (2020) (7)
90: Incidence of Benign Lesions for Clinically Localized Renal Masses < 7cm in Radiologic Diameter: Influence of Gender (2006) (7)
Nomogram to Predict Risk of Postoperative Urinary Retention in Women Undergoing Pelvic Reconstructive Surgery. (2020) (6)
On Risk Estimation versus Risk Stratification in Early Prostate Cancer (2016) (6)
Long-term survival of extremely advanced prostate cancer patients diagnosed with prostate-specific antigen over 500 ng/ml. (2014) (6)
Derivation and Validation of the Critical Bronchiolitis Score for the PICU. (2021) (6)
Nomograms are more meaningful than severity-adjusted institutional comparisons for reporting outcomes. (2006) (6)
Erratum: Clinical benefits of a multivariate prediction model for bladder cancer: A decision analytic approach (Cancer (2009) 115 (5460-5469)) (2011) (6)
Year of treatment is an independent predictor of outcome in patients with localized prostate cancer treated with definitive radiotherapy (2001) (6)
Prostate Cancer-Specific Mortality and Survival Outcomes for Salvage Radiation Therapy After Radical Prostatectomy. (2016) (6)
A Study of Personality and Leadership Styles among Members of a Rock Band (2014) (6)
Multi-cohort modeling strategies for scalable globally accessible prostate cancer risk tools (2019) (6)
Prognosis after androgen deprivation therapy in men with a rising PSA after prostatectomy (2005) (6)
Combined-Modality Staging for Localized Adenocarcinoma of the Prostate (2001) (6)
Comment on: Decisional Conflict, Regret, and the Burden of Rational Decision Making (2017) (6)
Risk prediction for severe hypoglycemia in a type 2 diabetes population with previous non-severe hypoglycemia. (2019) (6)
Predicting the outcome of salvage radiotherapy for recurrent prostate cancer after radical prostatectomy. (2006) (6)
Predictive modeling in prostate cancer: a conference summary. (2009) (6)
A new chemotherapy regimen for treatment of Hodgkin's disease associated with minimal genotoxicity. (1993) (6)
Predicting the long-term risk of prostate cancer-specific mortality after radical prostatectomy. (2009) (6)
Mechanisms of socioeconomic differences in COVID-19 screening and hospitalizations. (2021) (6)
The effect of isotope selection on the prostate-specific antigen response in patients treated with permanent prostate brachytherapy. (2003) (6)
Predicting Quality of Life After Radical Prostatectomy (2004) (6)
Predicting Personalized Risk of Mood Recurrences in Youths and Young Adults With Bipolar Spectrum Disorder. (2020) (6)
Validation of a Risk Calculator to Personalize Graft Choice and Reduce Rupture Rates for Anterior Cruciate Ligament Reconstruction (2021) (6)
Response to Comment on: Pantalone et al. The Risk of Overall Mortality in Patients With Type 2 Diabetes Receiving Glipizide, Glyburide, or Glimepiride Monotherapy: A Retrospective Analysis. Diabetes Care 2010;33:1224–1229 (2011) (6)
Nomograms for predicting the risk of arm lymphedema after axillary dissection in breast cancer. (2011) (5)
Minimally Invasive Therapy for Prostate Cancer: Use of Nomograms to Counsel Patients about the Choice and Probable Outcome of Therapy. (2004) (5)
Efficacy and safety of single agent pertuzumab (rhuMAb 2C4), a HER dimerization inhibitor, in hormone refractory prostate cancer after failure of taxane-based therapy (2005) (5)
Prostate Cancer Screening: A Brief Tool to Incorporate Patient Preferences in a Clinical Encounter (2016) (5)
Nomogram to predict successful placement in surgical subspecialty fellowships using applicant characteristics. (2012) (5)
Surgery confounds biology: The predictive value of stage‐, grade‐ and prostate‐specific antigen for recurrence after radical prostatectomy as a function of surgeon experience (2011) (5)
An Algorithm for Classifying Patients Most Likely to Develop Severe Coronavirus Disease 2019 Illness (2020) (5)
Predicting Prostate Cancer Recurrence After Radical Prostatectomy (2017) (5)
Comparing prediction tools. (2010) (5)
A Type 2 Diabetes Subtype Responsive to ACCORD Intensive Glycemia Treatment (2021) (5)
Prostate-Specific Antigen Trends Predict the Probability of Prostate Cancer in a Very Large U.S. Veterans Affairs Cohort (2018) (5)
Improving the Decision to Pursue a Phase 3 Clinical Trial by Adjusting for Patient-Specific Factors in Evaluating Phase 2 Treatment Efficacy Data (2007) (5)
International Multi-Site Initiative to Develop an MRI-Inclusive Nomogram for Side-Specific Prediction of Extraprostatic Extension of Prostate Cancer (2021) (5)
Evaluating a Marker's Contribution to a Nomogram: The GEMCaP Example (2009) (5)
A nomogram to predict the probability of passing the American Board of Internal Medicine examination. (2012) (5)
Protective heterologous T cell immunity in COVID-19 induced by MMR and Tdap vaccine antigens (2021) (5)
1192: A Nomogram to Predict the Outcome of Salvage Radiotherapy (RT) for Biochemical Recurrence (BCR) Following Radical Prostatectomy (RP) (2006) (5)
1208 URINARY PCA 3 AS A PREDICTOR FOR PROSTATE CANCER IN A COHORT OF 1928 MEN UNDERGOING INITIAL PROSTATE BIOPSY (2012) (5)
Predicting the cure rate of breast cancer using a new regression model with four regression structures (2018) (5)
1640: Development of a Nomogram to Predict Acute Urinary Retention or BPH-Related Surgery with or without Medical Therapy in Men with BPH Based on Data from the MTOPS Trial (2005) (4)
5α-Reductase Inhibitors Are Associated with Reduced Risk of SARS-CoV-2 Infection: A Matched-Pair, Registry-Based Analysis (2021) (4)
1190: Studies on Androgen Deprivation Therapy for a Rising PSA Prostatectomy: Development of Castrate Metastasis (Hormonally Refractory Prostate Cancer) (2006) (4)
798: The Association Between Body Mass Index (BMI) and Disease Progression in Clinically Localized Prostate Cancer (2004) (4)
Deriving benefit of early detection from biomarker-based prognostic models. (2013) (4)
Making and evaluating a statistical prediction model for the absolute risk of prostate cancer recurrence (2011) (4)
We should not be so quick to abandon the use of domain experts and full models (letter commenting: J Clin Epidemiol. 2015;71C:76--85.). (2016) (4)
The ultimate prostate cancer biopsy decision support tool. (2010) (4)
285 OVERALL AND CANCER SPECIFIC SURVIVAL FOLLOWING DEFINITIVE THERAPY FOR CLINICALLY LOCALIZED PROSTATE CANCER IN THE PROSTATE-SPECIFIC ANTIGEN ERA (2010) (4)
Screening for prostate cancer [2] (1995) (4)
A practical prediction model for determining bevacizumab response and toxicity in the treatment of advanced ovarian and peritoneal cancers – An analysis of GOG 218 (2012) (4)
The STHLM3 prostate cancer diagnostic study: calibration, clarification, and comments (2016) (4)
VALIDATION OF A NOMOGRAM FOR PREDICTING DISEASE RECURRENCE FOLLOWING RADICAL PROSTATECTOMY FOR CLINICALLY LOCALIZED PROSTATE CANCER (1999) (4)
Using the Movember Foundation’s GAP3 cohort to measure the effect of active surveillance on patient-reported urinary and sexual function—a retrospective study in low-risk prostate cancer patients (2021) (4)
Local Extent of Prostate Cancer at MRI versus Prostatectomy Histopathology: Associations with Long-term Oncologic Outcomes. (2021) (4)
Independent Predictors of Clinical Outcomes and Prediction Models for Renal Tumor Pathology (2015) (4)
Preoperative nomogram predicting 12-year probability of metastatic renal cancer - evaluation in a contemporary cohort. (2020) (4)
Guidelines for Reporting of Figures and Tables for Clinical Research in Urology. (2020) (4)
Screening for Lynch Syndrome in the General Population–Letter (2011) (4)
THE INFLUENCE OF PATHOLOGICAL PARAMETERS OF POSITIVE SURGICAL MARGINS ON PROGNOSIS IN PATIENTS UNDERGOING RADICAL PROSTATECTOMY (1999) (4)
A model for explaining and predicting the effectiveness of machine learning techniques (1993) (4)
VALIDATION OF THE PARTIN TABLES FOR PREDICTING PATHOLOGIC STAGE OF CLINICALLY CONFINED PROSTATE CANCER (1999) (4)
The many uses of cancer prediction tools. (2010) (4)
The probability of a positive bone scan in patients who were treated with adrogen ablasio therapy for rising PSA after radical prostatectomy. (2006) (4)
A multinational phase III adjuvant study of immediate (I) versus deferred (D) chemotherapy (C)/hormone therapy (HT) after radical prostatectomy (RP): TAX-3501. (2012) (4)
Predicting Pathological Stage of Localized Prostate Cancer-Reply (1997) (3)
671: Defining Biochemical Recurrence of Prostate Cancer after Radical Prostatectomy: A Proposal for a Standardized Definition (2005) (3)
An Independently Validated Nomogram for Individualized Estimation of Survival Among Patients With Newly Diagnosed Glioblastoma: NRG Oncology/RTOG 0525 and 0825 (2016) (3)
Stages of prediction model comparison. (2012) (3)
Intensification patterns and the probability of HbA1c goal attainment in Type 2 diabetes mellitus: real‐world evidence for the concept of ‘intensification inertia’ (2020) (3)
A comparison of two preoperative nomogram predicting recurrence following radical prostatectomy (2002) (3)
Pretreatment nomogram predicting the long-term risk of metastatic progression of prostate cancer after radical prostatectomy (2005) (3)
The current state of brachytherapy nomograms for patients with clinically localized prostate cancer (2009) (3)
Prostate cancer: Numeracy and understanding of risk reduction of PSA screening (2018) (3)
Previous history of bladder cancer as a prognostic factor for patients diagnosed with transitional cell carcinoma of the upper urinary tract (2004) (3)
Why Is Modeling Coronavirus Disease 2019 So Difficult? (2020) (3)
The Hypothetical Rabbit (2016) (3)
Derivation and validation of a machine learning risk score using biomarker and electronic patient data to predict rapid progression of diabetic kidney disease (2020) (3)
MP58-05 A NOMOGRAM PREDICTING TESTOSTERONE RESPONSE IN MEN ON CLOMIPHENE (2019) (3)
Development of a prognostic nomogram for liver toxicity in patients treated with pazopanib. (2017) (3)
PROGNOSTIC NOMOGRAM FOR THE ESTIMATION OF SERUM TESTOSTERONE LEVEL FOLLOWING VARICOCELE LIGATION (2008) (3)
Development and validation of a prognostic nomogram for progression-free and overall survival in patients with advanced renal cell carcinoma (aRCC) treated with pazopanib. (2014) (3)
OR4 UTILITIES SHOULD NOT BE MULTIPLIED: EVIDENCE FROM THE PREFERENCE-BASED SCORES IN THE UNITED STATES (2008) (3)
1352: Baseline Serum BPH-A Level Enhances the Accuracy of a Nomogram to Predict BPH Progression in Men Enrolled on the GSK Phase III Dutasteride Trials (2006) (3)
Tailored cancer outcome prediction and informed consent. (2010) (3)
VALIDATION AND COMPARISON OF THE TWO KATTAN NOMOGRAMS IN PATIENTS WITH PROSTATE CANCER TREATED WITH 125IODINE BRACHYTHERAPY (2012) (3)
The multinomial logistic regression model for predicting the discharge status after liver transplantation: estimation and diagnostics analysis (2019) (3)
Decision models for distinguishing between clinically insignificant and significant tumors in prostate cancer biopsies: an application of Bayes’ Theorem to reduce costs and improve outcomes (2020) (3)
1363: Prediction of Prostate Volume Using Molecular forms of PSA in Men with BPH Enrolled on the GSK PHASE III Dutasteride Trials (2006) (2)
Validation of the Decipher prostate cancer classifier for predicting 10-year postoperative metastasis from analysis of diagnostic needle biopsy specimens. (2016) (2)
1661: Predicting the 10-Year Probability of Prostate Cancer Recurrence After Radical Prostatectomy: A New Preoperative Nomogram (2005) (2)
Risk Prediction Versus Diagnosis: Preserving Clinical Nuance in a Binary World (2009) (2)
1617: Low Pretreatment Total Testosterone Levels are Associated with a Predominance of Pattern 4 Prostate Cancer at Prostatectomy and Risk of Biochemical Recurrence (2007) (2)
730 Decipher genomic classifier measured on prostate biopsy predicts 10 year metastasis risk (2016) (2)
A Hybrid Approach to Survival Model Building Using Integration of Clinical and Molecular Information in Censored Data (2012) (2)
3-point major cardiovascular event outcome for patients with T2D treated with dipeptidyl peptidase-4 inhibitor or glucagon-like peptide-1 receptor agonist in addition to metformin monotherapy (2020) (2)
Multicenter Analysis of Impact of High Biologically Effective Dose (BED) on Biochemical Failure (Phoenix Definition) and Survival Outcomes in Patients With Gleason Score 7–10 Prostate Cancer Treated by Permanent Prostate Brachytherapy (2007) (2)
Associations of weight loss with obesity‐related comorbidities in a large integrated health system (2021) (2)
Use of Visual Decision Aids in Physician–Patient Communication (2017) (2)
Predicting progression in patients followed with active surveillance for low-risk prostate cancer. (2014) (2)
Nomograms and the Elderly: Applications in Genitourinary Oncology (2013) (2)
Promise and pitfalls of prognostic models for epilepsy surgery—Authors' reply (2015) (2)
1785: The Impact of Tumor Location on Histologic Subtype of Renal Cortical Tumors (2004) (2)
Empirical Treatment Effectiveness Models for Binary Outcomes (2016) (2)
Modeling Individual Patient Preferences for Colorectal Cancer Screening Based on Their Tolerance for Complications Risk (2017) (2)
440: Clinical Course and Response to First-Line Androgen Deprivation Therapy in Patients with PSA-Progression After Radical Prostatectomy (2004) (2)
Somatic mutations as preoperative predictors of metastases in patients with localized clear cell renal cell carcinoma - An exploratory analysis. (2021) (2)
Prediction models for transitional cell carcinoma. (2009) (2)
The Cost-Effectiveness of Epilepsy Surgery and Surgical Evaluation in the United States (2019) (2)
MP58-14 DECISION ANALYSIS MODEL TO FACILITATE TREATMENT DECISION-MAKING FOR LOCALIZED PROSTATE CANCER: RESULTS OF A RANDOMIZED TRIAL (2014) (2)
Testing of a Tool for Prostate Cancer Screening Discussions in Primary Care (2018) (2)
212: Role of Surgeon and Surgeon Volume in Erectile Function Recovery after Radical Prostatectomy (2006) (2)
A Decision Analysis To Determine the Appropriate Treatment for Low-Risk Myelodysplastic Syndromes. (2005) (2)
A genomic classifier to improve prediction of metastatic disease within 5 years after surgery in node-negative high-risk prostate cancer patients managed by radical prostatectomy without adjuvant therapy. (2015) (2)
Utility of PCA3 and TMPRSS2:ERG urinary biomarkers in African American men undergoing prostate biopsy. (2016) (2)
Percentage of free PSA (%FPSA) is not an independent predictor of pathologic stage or psa recurrence in patients with localised prostate cancer treated with Radical Prostatectomy (RP) (2002) (2)
Guidelines for Reporting of Figures and Tables for Clinical Research in Urology. (2020) (2)
Development and validation of a model to predict outcomes of colon cancer surveillance (2019) (2)
856: A Pretreatment Nomogram for Predicting the Need for Additional Therapy Following Radical Prostatectomy for Prostate Cancer (2004) (2)
Variation in preoperative stress testing by patient, physician and surgical type: a cohort study (2021) (2)
MP39-11 BASELINE PSA BEFORE AGE 60 AS A PREDICTOR OF IMPORTANT PROSTATE CANCER DIAGNOSIS AND PROSTATE CANCER-SPECIFIC MORTALITY IN THE INTERVENTION ARM OF THE PROSTATE, LUNG, COLORECTAL AND OVARIAN TRIAL (2016) (2)
1137: Natural History of Biochemically-Recurrent Castrate-Resistant Disease in Men Treated with Maximal Androgen Blockage for a Rising PSA after Radical Prostatectomy (2005) (2)
Predictive Factors in Prostate Cancer: Implications for Decision Making (2003) (2)
A Tool for Shared Decision Making on Referral for Prostate Biopsy in the Primary Care Setting: Integrating Risks of Cancer with Life Expectancy (2019) (2)
1491: Measurements of Urokinase Receptor Fractions and Human Glandular Kallikrein 2 in Serum Improves Discrimination of Men with Prostate Cancer from Men with no Evidence of Malignant Disease (2005) (1)
Response to Comment on Pantalone et al. The Probability of A1C Goal Attainment in Patients With Uncontrolled Type 2 Diabetes in a Large Integrated Delivery System: A Prediction Model. Diabetes Care 2020;43:1910–1919 (2020) (1)
Development and Internal Validation of A Prediction Tool To Assist Clinicians Selecting Second-Line Therapy Following Metformin Monotherapy For Type 2 Diabetes. (2020) (1)
104 : An Updated 9-Year Preoperative Nomogram Predicting for Prostate Cancer Recurrence After Permanent Prostate Brachytherapy (2006) (1)
Estimating The Cost For Prostate Cancer (Pca) Screening Using The Prostate, Lung, Colorectal And Ovarian Cancer Screening Trial Data (2013) (1)
Predicting Six-year Mortality Risk in Patients with Type 2 Diabetes (2008) (1)
Editorial: Why is modeling COVID-19 so difficult? (2020) (1)
PREOPERATIVE PLASMA IGF-1 LEVELS DO NOT CORRELATE WITH FINAL PATHOLOGIC STAGE OR PROGRESSION IN PATIENTS UNDERGOING RADICAL PROSTATECTOMY (1999) (1)
Changing demographics and the contemporary surgical management of renal cortical tumors. (2004) (1)
Nomogram predicting treatment-related sexual dysfunction for men with localized prostate cancer treated by radical prostatectomy (RP), external-beam radiotherapy (EBRT), and brachytherapy (PI). (2012) (1)
RECALIBRATION AND EXTERNAL VALIDATION OF AN EXISTING NOMOGRAM TO PREDICT AGGRESSIVE RECURRENCES AFTER RADICAL PROSTATECTOMY (RP) (2009) (1)
Immunochemistry for p 16 , but not Rb or p 21 , is an independent predictor of prognosis in conservatively treated , clinically localised prostate cancer (2015) (1)
Guidelines for Reporting of Figures and Tables for Clinical Research in Urology. (2020) (1)
Predicting 6-Year Mortality Risk in Patients With Type 2 Diabetes (2009) (1)
Su1266 – Helicobacter Pylori Testing and Treatment in a Large, Integrated Healthcare Delivery System in the United States (2019) (1)
Optimizing Clinical Outcome and Toxicity in Lung Cancer Using a Genomic Marker of Radiosensitivity (2020) (1)
404-P: Cardiovascular Risk Scoring and Stratification in Patients with Type 2 Diabetes Enrolled in a Medicare Advantage Plan (2020) (1)
Impacts of COVID-19 on glycemia and risk of diabetic ketoacidosis (2022) (1)
Validation of a nomogram for predicting disease-specifi c survival following a R 0 resection for gastric cancer (2007) (1)
International validation of a nomogram for predicting disease-specific survival following an R0 resection for gastric cancer in a multicenter patient population. (2004) (1)
Modeling potential time to event data with competing risks (2014) (1)
Comparing the ability of clinicians and a nomogram model at predicting future 99mTc-bone scan (BS) positivity in patients (pts) with rising prostate-specific antigen (PSA) following radical prostatectomy (RP) for prostate cancer (PCa). (2012) (1)
1188: 15-year Cancer-Specific and Psa-Progression free Rates after Radical Prostatectomy (2004) (1)
1639: Development of a Nomogram to Predict Symptom Progression with or without Medical Therapy in Men with BPH Based on Data from the MTOPS Trial (2005) (1)
Clinical Risk Assessment and Prediction (2019) (1)
Independent validation of a genomic classifier in an at-risk population of men conservatively managed after radical prostatectomy. (2014) (1)
Pre-treatment nomogram to predict potency after treatment for localized prostate cancer. (2016) (1)
The REDUCE metagram: a comprehensive prediction tool for determining the utility of dutasteride chemoprevention in men at risk for prostate cancer (2012) (1)
Prognostic factors predictive of response to bevacizumab combined with chemotherapy in recurrent ovarian cancer – A multi-institutional study (2012) (1)
Development of a nomogram to predict for all-cause and cancer-specific mortality in high-risk prostate cancer treated by external beam radiotherapy and androgen deprivation. (2013) (1)
SIOG (INTERNATIONAL SOCIETY OF GERIATRIC ONCOLOGY) (2008) (1)
Prediction of future risk of any and higher-grade prostate cancer based on the PLCO and SELECT trials (2022) (1)
NOMOGRAM PREDICTIVE OF PATHOLOGICAL INGUINAL LYMPH NODE (2006) (1)
Nomogram to Predict Prostate Cancer Diagnosis on Primary Transrectal Ultrasound-Guided Prostate Biopsy in a Contemporary Series (2012) (1)
COMPARISON OF RISK STRATIFICATION MODELS AND THE KATTAN PREOPERATIVE NOMOGRAM IN PREDICTION OF FREEDOM FROM PSA RELAPSE AFTER RADICAL PROSTATECTOMY (2009) (1)
GARD is a pan-cancer predictor of clinical outcome in radiation treated patients. (2020) (1)
An Externally Validated Nomogram for Predicting Distant Metastasis after Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer: Implications for Adjuvant Systemic Therapy (2018) (1)
Changing demographics and the contemporary surgical management of renal cortical tumors (2004) (1)
Prostate cancer specific mortality and overall survival outcomes for salvage radiation therapy after radical prostatectomy. (2017) (1)
855: Development of PRE and Post-Operative Nomograms for Erectile Function Recovery after Radical Prostatectomy (2007) (1)
Staging and Risk Stratification in Penile Cancer (2013) (1)
Development and validation of pretreatment nomogram for disease‐specific mortality in gastric cancer‐A competing risk analysis (2021) (1)
Prediction Models in Prostate Cancer Diagnosis (2013) (1)
807: Achieving Optimal Outcomes After Radical Prostatectomy (2004) (1)
NOMOGRAM PREDICTING BOWEL DYSFUNCTION FOR MEN WITH LOCALIZED PROSTATE CANCER TREATED BY RADICAL PROSTATECTOMY, EXTERNAL‐BEAM RADIOTHERAPY, OR BRACHYTHERAPY: MP93‐03 (2017) (1)
Targets without tolerances: improper evaluation of medical personnel. (2018) (1)
Assessment of Clinical Outcomes, Clinical Manifestations, and Risk Factors for Hepatic Infarction After Transjugular Intrahepatic Portosystemic Shunt Placement (TIPS): A Retrospective Comparative Study (2022) (1)
Development and Internal Validation of the First Set of Nomograms Predicting Late Rectal Toxicity in Prostate Cancer Patients Undergoing 3D-CRT (2009) (1)
External validation of a sunitinib prognostic nomogram in patients (pts) with metastatic renal cell carcinoma (mRCC). (2012) (1)
Editorial comment. (2014) (1)
1460 OVERALL SURVIVAL (OS) AND PROSTATE CANCER-SPECIFIC MORTALITY (PCSM) AMONG CONTEMPORARY MEN WITH SCREEN-DETECTED, LOCALIZED PROSTATE CANCER MANAGED BY ACTIVE SURVEILLANCE (AS) VERSUS DEFINITIVE LOCAL THERAPY (2011) (1)
Understanding Treatment Response in Individual Profiles of Men with Prostatic Enlargement at Risk of Progression. (2022) (1)
MRI-Detectability of Clinically Significant Prostate Cancer Relates to Oncologic Outcomes After Prostatectomy. (2022) (1)
BRACHYTHERAPY DOSES FOR PROSTATE CANCER CUSTOMIZED TO RISK FACTORS : IS IT MORE IMPORTANT HOW MUCH OR WHERE ?IN REGARD TO STONE ET AL. (INT J RADIA T ONCOL BIOL PHYS 2007;69:1472-1477). Aurhos' reply (2008) (1)
P-045 Testis biopsy image analysis quantification is highly correlated with FSH levels in infertile men (1997) (1)
Contemporary Update of a Multi-institutional Predictive Nomogram for Salvage Radiation Therapy After Prostatectomy (2015) (1)
Accommodating heterogeneous missing data patterns for prostate cancer risk prediction (2021) (1)
491: Studies on Rising PSA After RP: Trends on Secondary Treatments (2006) (1)
787: Predicting The 10-Year Probability of Prostate Cancer Recurrence: An Updated Postoperative Nomogram and a Suite of Nomograms for Patients who are Free of Disease at One to Five Years after Radical Prostatectomy (2004) (1)
Erratum. Predicting 10-Year Risk of End-Organ Complications of Type 2 Diabetes With and Without Metabolic Surgery: A Machine Learning Approach. Diabetes Care 2020;43:852–859 (2020) (1)
Nomogram predicting treatment-related urinary incontinence for men with localized prostate cancer treated by radical prostatectomy (RP), external-beam radiotherapy (EBRT), or brachytherapy (PI). (2012) (1)
The Utility of Nomograms in Routine Clinical Practice (2012) (1)
POD-05.08: Predicting the Long-Term Risk of Prostate Cancer-Specific Mortality After Radical Prostatectomy (2009) (1)
Prostate Cancer Nomograms and How They Measure Up to Neural Networks (2008) (1)
470 DO MARGINS MATTER? THE INFLUENCE OF POSITIVE SURGICAL MARGINS ON PROSTATE CANCER-SPECIFIC MORTALITY (2011) (1)
T1295 Development of a Nomogram for Prediction of Pouch Failure in Ulcerative Colitis (UC) Patients With Restorative Proctocolectomy (2010) (1)
20 : Customized Dose Prescription for Prostate Brachytherapy: Insights From a Multicenter Analysis of Dosimetry Outcomes (2006) (1)
Abstract P3-09-09: Assessing utility of breast cancer risk assessment tool in comparison to Tyrer-Cuzick model for determination of breast cancer risk and implications for chemoprevention (2018) (1)
Detection of prostate cancer in an ethnically diverse, disadvantaged population with multiple prostate specific antigen measurements before biopsy. (2012) (1)
Development of a nomogram model using a very large sample of patients (pts) to predict the risk of 99mTc-bone scan (BS) positivity in pts receiving androgen deprivation therapy (ADT) for prostate cancer (PCa). (2012) (1)
Independent Predictors of Clinical Outcomes and Prediction Models on Bladder and Upper Urinary Tract Cancer (2015) (1)
1795 COMPARATIVE ANALYSIS OF PREDICTIVE ACCURACY OF RISK ASSESSMENT TOOLS IN AUSTRALIAN PROSTATE CANCER PATIENTS (2011) (1)
1305 POSTER SIOG (International Society of Geriatric Oncology) prostate cancer guidelines proposals in senior adult men (2007) (1)
MA01.03 An Externally Validated Nomogram for Predicting Distant Metastasis After SBRT for Early Stage Non-Small Cell Lung Cancer (2018) (1)
Nomogram for predicting 5-year survival after primary surgery for epithelial ovarian cancer. (2009) (1)
pT3N0 PROSTATE CANCER PATIENTS WITH RT-PCR-hK2-L-POSITIVE LYMPH NODES ARE AT HIGHER RISK FOR RECURRENCE (1999) (1)
Postoperative N omogram f or D isease R ecurrence After R adical P rostatectomy f or P rostate C ancer (1999) (1)
1781: Contemporary Surgical Management of Renal Cortical Tumors of 7 CM or Less (2004) (1)
Impact of central pathology review (CPR) of radical prostatectomy (RP) specimens for patient selection in the surgical adjuvant trial in prostate cancer (PCa) TAX-3501 (2008) (1)
Survival and conservative treatment for localized prostate cancer. (1996) (1)
Cardiovascular risk prediction model and stratification in patients with type 2 diabetes enrolled in a Medicare Advantage plan. (2021) (1)
Siog (international society of geriatric oncology) localised prostate cancer guidelines proposals in senior adult men (2008) (1)
The Development and Execution of Medical Prediction Models (2007) (1)
800: Presence of Peripheral Zone Cancer at the Apical Shave is Important Prognostic Factor (2004) (1)
Natural history of prostate cancer in a large cohort of untreated patients in the United Kingdom (2005) (1)
Local ized Prostate Cancer (2003) (1)
Ki-67 is an independent predictor of outcome in conservatively treated clinically localised prostate cancer (2008) (1)
Determining the area under the receiver operating characteristic curve for a binary diagnostic test: Best is not always ideal (multiple letters) (2001) (1)
Clinical stage T2 prostate cancer treated with radical prostatectomy has similar outcome across its substages (2002) (1)
Response to Kerr et al (2017) (1)
Resting heart rate in ambulatory heart failure with reduced ejection fraction treated with beta‐blockers (2020) (1)
Prostate cancer: nomograms and risk assessment models. (2003) (1)
PROGNOSTIC NOMOGRAMS FOR PREDICTION OF SURVIVAL BEFORE OR AFTER CYTOREDUCTIVE NEPHRECTOMY FOR METASTATIC RENAL CELL CARCINOMA (2009) (1)
Implementation Experience with a 30-Day Hospital Readmission Risk Score in a Large, Integrated Health System: A Retrospective Study (2022) (1)
1139: Predicting Time to Metastatic Progression from Biochemical Recurrence after Radical Prostatectomy (2005) (1)
The use of a Nomogram to Predict the Risk of Intermittent Self-Catheterization After Prostate Brachytherapy (2007) (0)
A comprehensive and novel predicative modeling technique using detailed pathology factors in men with localized prostate cancer (2001) (0)
Reply to commentary on “Predicting seizure freedom after epilepsy surgery, a challenge in clinical practice” (2019) (0)
Principles and Design Considerations of Clinical Trials (2015) (0)
From database to clinic: Using a multivariable recurrence risk calculator to guide Merkel cell carcinoma surveillance (2022) (0)
In Reply: Radical Retropubic Prostatectomy (1995) (0)
Characterization, resource use, and the economic impact of low-risk myelodysplastic syndrome (MDS) at an MDS specialty center (2005) (0)
Contents Vol. 1, 2007 (2008) (0)
Abstract 21098: Variables From the CMS Heart Failure Readmission Model Poorly Predict 30-Day Rehospitalization Risk in Heart Failure Patients From a Large Academic Hospital System (2017) (0)
POD-5.02: Clinical Application of Chromosome 8q24 SNP 's in Prostate Cancer Detection (2008) (0)
1000: Prediction and Natural History of Organ Confined Prostate Cancer after RP (2005) (0)
Addressing Therapeutic Inertia: Development and Implementation of an Electronic Health Record–Based Diabetes Intensification Tool (2022) (0)
S096 Nomogram for Predicting Locoregional Recurrence-Free Survival After Treatment of Oral Cavity Squamous Cell Carcinoma (2006) (0)
Predicted benefit of alternative post-treatment surveillance strategies in stage II and III colon cancer survivors. (2016) (0)
PD38-07 PROMPT – PROSTATE GENETIC SCORE IMPROVES THE PERFORMANCE OF ESTABLISHED PROSTATE CANCER RISK CALCULATORS (2020) (0)
Development and Validation of the First AJCC Compliant Clinical Staging System for Localized Prostate Cancer: Results from a Multicenter International Study (2019) (0)
1159 PREDICTING THE RISK OF BLADDER CANCER AND HIGH-GRADE BLADDER CANCER USING PATIENT CLINICAL AND DEMOGRAPHIC INFORMATION FROM PLCO PARTICIPANTS (2010) (0)
Modeling potential time to event data with competing risks (2013) (0)
Letters to the Editor/Errata Re: Location, Extent and Number of Positive Surgical Margins do Not Improve Accuracy of Predicting Prostate Cancer Recurrence After Radical Prostatectomy (2011) (0)
Decision models for distinguishing between clinically insignificant and significant tumors in prostate cancer biopsies: an application of Bayes’ Theorem to reduce costs and improve outcomes (2019) (0)
853: Bone Scan in Assessing Biochemical Failure After Radical Prostatectomy – Efficacy and Risk Factors for a Positive Scan (2004) (0)
External validation of an all-stage ovarian cancer nomogram: Is BRCA status more predictive than family history? (2014) (0)
1103 SURVIVAL ANALYSIS AFTER PROSTATE CANCER TREATMENT AMONG HEALTHY MEN: MULTI-INSTITUTIONAL STUDY OF 6692 PATIENTS (2011) (0)
SURGERY AS A CONFOUNDER OF BIOLOGY: THE PREDICTIVE VALUE OF STAGE, GRADE AND PROSTATE-SPECIFIC ANTIGEN (PSA) FOR RECURRENCE IS A FUNCTION OF SURGEON EXPERIENCE (2008) (0)
Pretreatment N omogram f or P redicting t he O utcome of T hree-Dimensiona l C onformal R adiotherapy i n Prostate C ancer (2000) (0)
Clinical Trials and Their Principles (2008) (0)
161 PREDICTING ALL-CAUSE AND PROSTATE CANCER SPECIFIC MORTALITY FOLLOWING DEFINITIVE THERAPY FOR LOCALIZED PROSTATE CANCER (2012) (0)
MP56-08 INCIDENCE OF SEVERE BLADDER INJURY AMONG THE MONOPOLAR AND BIPOLAR TRANSURETHRAL RESECTION OF BLADDER TUMOR: A POPULATION-BASED STUDY BASED ON 28141 CASES (2014) (0)
Predictive Models in Castration Resistant Prostate Cancer (2016) (0)
Prostate cancer: Searching for an effective prediction tool (2007) (0)
Clinical Cancer esearch an Cancer Biology Relationship between Prostate-Specific Antigen and state Cancer Risk : The Prostate Biopsy R laborative Group (2010) (0)
1682: Development of a Nomogram for the Assessment of Cadaveric Donor Kidneys for Transplantation (2006) (0)
Abstract 15025: Validation of the TRA2°P TIMI50 Risk Score for Predicting Cardiovascular Events in Real World Patients (2016) (0)
Association between first-line monotherapy with metformin and the risk of atrial fibrillation (AMRAF) in patients with type 2 diabetes. (2022) (0)
A Comparison of NASA Induction Tools for the Creation of Decision Rules Regarding Treatment for Clinically Localized Prostate Cancer (1997) (0)
Predicting overall survival after secondary surgical cytoreduction for platinum-sensitive recurrent ovarian cancer: a prognostic nomogram (2014) (0)
Assessment of Hepatocellular Carcinoma Recurrence Risk After Primary Treatment Using Predictive Nomograms (2013) (0)
Computational modeling for censored time to event data using data integration in biomedical research (2011) (0)
Editorial Comment. (2018) (0)
VALIDATION OF A PREOPERATIVE NOMOGRAM FOR SOLID ENHANCING RENAL TUMORS (2009) (0)
MP28-19 A NEW RISK CALCULATOR TO PREDICT CHANGES IN INTERNATIONAL PROSTATE SYMPTOM SCORE AND RISK OF RETENTION OR SURGERY IN BENIGN PROSTATIC HYPERPLASIA PATIENTS WITH MODERATE-SEVERE SYMPTOMS AT RISK OF DISEASE PROGRESSION RECEIVING PLACEBO, DUTASTERIDE, TAMSULOSIN, OR COMBINATION THERAPY (2021) (0)
Paper Standard Gamble Is a Useful Utility and Patient Reported Outcome Measure in Crohnʼs Disease (2018) (0)
Radiotherapy with genomic-adjusted radiation dose - Authors' reply. (2021) (0)
2333 AN IMPROVED NOMOGRAM FOR PREDICTION OF THE OUTCOME OF THE INITIAL STANDARD PROSTATE BIOPSY IN PATIENTS WITH PSA ≥10 BASED ON EASILY OBTAINABLE CLINICAL DATA (2011) (0)
65 A multi-institutional nomogram for predicting the outcome of ultrasound guided transperineal brachytherapy in prostate cancer (2000) (0)
Does Choosing Autograft Hamstring vs. Patellar Tendon by Gender, Sport, Level of Competition or Laxity in High School and College Aged Athletes Improve KOOS, IKDC or Marx? (2016) (0)
6633 POSTER Conditional Probability of Survival Nomogram After an R0 Resection for Gastric Cancer (2011) (0)
Abstract IA03: Requirements for a statistical prediction model to receive AJCC endorsement (2017) (0)
Does my model predict accurately? (2021) (0)
657 Nomogram to predict the outcomes of intracytoplasmic sperm injection (ICSI) (2018) (0)
A nomogram to predict the probability of passing the American Board of Internal Medicine examination. (2012) (0)
Quantification of total and high-grade cancer in biopsy cores improves the prediction of PSA recurrence after Radical Prostatectomy (RP) (2002) (0)
Editorial comment. (2012) (0)
ESTIMATING PROSTATE CANCER RELATIVE SURVIVAL AND CANCER-SPECIFIC DEATH (2015) (0)
Prospective evaluation of testosterone (T) recovery and PSA relapse following 18 months of androgen deprivation (ADT) after prostatectomy (RP): Results from the TAX-3501 trial. (2013) (0)
Upper GI 04 (2009) (0)
Commentary: Meta-Analyses Reporting the Prognostic Value of Androgen Receptor Splice Variant 7 in Castration-Resistant Prostate Cancer (2020) (0)
Incidence of reduced penis size among men with recurrent prostate cancer previously treated with surgery, radiation plus androgen deprivation, or radiation alone. (2012) (0)
Role of nomograms in the management of prostate cancer (2011) (0)
Postoperative Myocardial Infarction and In-Hospital Mortality Predictors in Patients Undergoing Elective Noncardiac Surgery (2010) (0)
Correction: Screening for Lynch Syndrome in the General Population—Letter (2011) (0)
Refer for prostate biopsy? A prediction tool combining risk of significant prostate cancer and life expectancy for UK primary care (2018) (0)
Nomogram predicting 5-year progression-free survival after secondary surgical cytoreduction for platinum-sensitive recurrent ovarian cancer (2014) (0)
437 NOMOGRAM PREDICTING URINARY INCONTINENCE FOR MEN WITH LOCALIZED PROSTATE CANCER TREATED BY RADICAL PROSTATECTOMY, EXTERNAL-BEAM RADIOTHERAPY, AND BRACHYTHERAPY (2013) (0)
1918 DEVELOPMENT OF AN IMPROVED NOMOGRAM FOR PREDICTION OF THE OUTCOME OF THE INITIAL PROSTATE BIOPSY BASED ON READILY AVAILABLE CLINICAL INFORMATION (2011) (0)
Outcomes: Prognostic Factors, Models, and Algorithms (2019) (0)
Public Health Interventions’ Effect on Hospital Use in Patients With COVID-19: Comparative Study (Preprint) (2020) (0)
GARD is a Pan-Cancer Predictor of Outcome and Radiation Treatment Benefit (2021) (0)
THE PERCEPTION OF FAMILY HISTORY RISK AND ITS ESTIMATE ROLE OF HAVING PROSTATE CANCER IN THE CONTEMPORARY ERA (2009) (0)
1452: Defining the Characteristics of Locally Recurrent Prostate Cancer After Radical Prostatectomy Based on the Results of Salvage Radiotherapy: a Multi-Center Analysis (2004) (0)
Letter Response. (2021) (0)
International society of geriatric oncology (SIOG) proposal of guidelines for advanced prostate cancer in senior adults (2008) (0)
Effects of Toasting on the Quality of Canned Rice (2006) (0)
1175: EXTERNAL VALIDATION OF THE CRITICAL BRONCHIOLITIS SCORE FOR THE PEDIATRIC INTENSIVE CARE UNIT (2020) (0)
NOMOGRAM TO PREOPERATIVELY PREDICT THE PROBABILITY OF EPIDIDYMOVASOSTOMY (2008) (0)
MP26-03 PROPHYLACTIC ANTIBIOTICS IN TRANSPERINEAL PROSTATE BIOPSIES. ARE THEY REALLY NECESSARY? (2021) (0)
Intensive Care Unit Predicting Discharge to a Long-Term Acute Care Hospital After Admission (2014) (0)
Gene-based prediction of PSA recurrence for clinically localized prostate cancer patients. (2009) (0)
PD24-03 A PREOPERATIVE PROGNOSTIC NOMOGRAM FOR PREDICTING CHANGES IN SEMEN PARAMETERS IN INFERTILE MEN AFTER VARICOCELE REPAIR (2014) (0)
Can Sural Nerve Grafting Restore Potency in Humans ? (2001) (0)
Performance Decision Rules for Students in an Introductory Information Systems Course: A Recursive Partitioning Approach (2016) (0)
Guidelines for Reporting of Figures and Tables for Clinical Research in Urology (2020) (0)
Estimating Prostate Cancer Net Survival and Cancer-Specific Death (2014) (0)
Increased Biologic Use and Lower Surgical Rates in Pediatric Versus Adult-Onset Crohn’s Disease at a Large Tertiary-Care Center Over a 6-Year Follow-Up (2017) (0)
Predictors of severe CRS in longitudinal CAR T-cell clinical trial data. (2022) (0)
474 ASSOCIATION OF THE NUMBER OF LYMPH NODES (LN) REMOVED AT RADICAL PROSTATECTOMY WITH ALL-CAUSE (ACM) AND PROSTATE CANCER-SPECIFIC MORTALITY (PCSM) (2011) (0)
1983 INITIAL DIAGNOSIS OF HIGH-GRADE PROSTATIC INTRAEPITHELIAL NEOPLASIA IS A RISK FACTOR FOR SUBSEQUENT DEVELOPMENT OF PROSTATE CANCER (2010) (0)
The role of external radiotherapy and permanent prostate brachytherapy in patients with localized prostate cancer: a matched pair analysis (2001) (0)
Incidence and Predictors of Postoperative Heart Failure in Patients Undergoing Elective Noncardiac Surgery (2010) (0)
A Preoperative Nomogram Identifying Risk of Seminal Vesical Invasion in patients with Prostate Caner: A Multi-Institutional Study in 6740 Patients(Poster). (2006) (0)
651: Long-Term Risk of Metastatic Progression of Prostate Cancer Following Radical Prostatectomy (2006) (0)
The Influence of Patient Baseline Data and Mental Health in Predicting Outcomes after Hip Arthroscopy for Femoracetabular Impingement Syndrome: A Prospective Cohort Analysis (2019) (0)
Prospective evaluation of a new patient decision aid to enhance prostate cancer screening decision-making. (2019) (0)
A Postoperative Nomogram for Detecting 13-year Probability of Disease Recurrence from Prostate Cancer. (2006) (0)
205: Variations in Prostate Cancer Care According to Race, Geographic Region, and Literacy: Initial Findings from the Compare Registry (2006) (0)
PD27-12 DEVELOPMENT OF NOMOGRAMS TO PREDICT TESTOTERONE RECOVERY AFTER CESSATION OF ANDROGEN DEPRIVATION THERAPY IN MEN WITH PROSTATE CANCER (2018) (0)
FAST OA: PREDICTORS OF POST-TRAUMATIC OSTEOARTHRITIS SYMPTOMS 2 YEARS AFTER ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION (2022) (0)
Editorial comment. (2010) (0)
PREDICTING PATHOLOGICAL STAGE OF LOCALIZED PROSTATE CANCER. AUTHORS' REPLY (1997) (0)
CLINICAL APPLICATION OF CHROMOSOME 8q24 SNPs IN PROSTATE CANCER DIAGNOSIS (2008) (0)
When to order genomic tests: development and external validation of a model to predict high-risk prostate cancer at the genotypic level (2021) (0)
1585 THE IMPACT OF PERIOPERATIVE TRANSFUSION ON SURVIVAL CHARACTERISTICS IN SURGICALLY TREATED MEN WITH TRANSITIONAL CELL CARCINOMA OF THE BLADDER (2012) (0)
Benefit of Elective Nodal Irradiation and Androgen Deprivation Therapy with Postprostatectomy Salvage Radiation Therapy for Prostate Cancer (2016) (0)
Words of Wisdom. Re: Predicting Life Expectancy in Men Diagnosed with Prostate Cancer. (2015) (0)
Using the landmark method for creating prediction models in large datasets derived from electronic health records (2014) (0)
Tu1707 – Patient Reported Measures of Health Status Overestimate Differences in Quality of Life in Pediatric Crohn's Disease (2019) (0)
Response to: Noncancer Cells in Tumor Samples May Bias the Predictive Genomically Adjusted Radiation Dose. (2021) (0)
Treatment Example Preference Assessment Method Affects Decision-Analytic Recommendations : A Prostate Cancer (2004) (0)
Use of predictive models (PMs) in colorectal cancer (CRC) for diagnosis of Lynch syndrome (LS): A process measure for quality of care. (2012) (0)
Adult UrologyEditorial Comment (2002) (0)
111 PROSTATE BRACHYTHERAPY: NOMOGRAM COMPARISON WITH SURGICAL OUTCOME (2009) (0)
Issue information (2013) (0)
Unmet needs and opportunities for optimal management of patients with type 2 diabetes and chronic kidney disease. (2023) (0)
Conditional survival nomogram after an R0 resection for gastric cancer. (2011) (0)
S1287 Radiomic Features on Baseline Magnetic Resonance Enterography Are Prognostic of Disease Severity in Pediatric Crohn’s Disease (2021) (0)
Comorbidity and treatment regret in men with recurrent prostate cancer. (2011) (0)
Adding propensity scores to pure prediction models fails to improve predictive performance (2013) (0)
How do I decide between rival models? (2021) (0)
Gastric cancer new nomograms based on preoperative clinical prognostic factors. (2014) (0)
Inadequate Heart Rate Control in Ambulatory Patients with Systolic Heart Failure Despite Broad Beta Blocker Utilization: A Single Center Experience (2015) (0)
NOMOGRAM TO PREDICT PROSTATE CANCER DIAGNOSIS ON TRANSRECTAL ULTRASOUND-GUIDED PROSTATE BIOPSY IN A CONTEMPORARY SERIES (2008) (0)
EVAULATING THE ACCURACY OF A PREDICTIVE MODEL IN SURVIVAL ANALYSIS (2004) (0)
MP74-06 INDEPENDENT VALIDATION OF A GENOMIC CLASSIFIER IN AN AT RISK POPULATION OF MEN CONSERVATIVELY MANAGED AFTER RADICAL PROSTATECTOMY (2014) (0)
Dose Response for Salvage Radiation Therapy After Radical Prostatectomy in Margin-Positive Prostate Cancer (2015) (0)
Retrospective evaluation of the Adjuvant! for breast cancer after 5 years of adjuvant tamoxifen (AAT) and other factors for prediction of recurrences (OFPR) following 5 years of adjuvant tamoxifen (AT). (2011) (0)
991 PROSPECTIVE MULTI-INSTITUTIONAL STUDY EVALUATING THE PERFORMANCE OF PROSTATE CANCER RISK CALCULATORS (2011) (0)
Nomogram for prediction of prognosis in patients treated for oral cavity squamous cell carcinoma. (2012) (0)
The impact of body mass index on treatment recommendations for patients with intermediate risk prostate cancer. (2014) (0)
Nomogram f or O verall S urvival o f P atients W ith Progressive M etastatic P rostate C ancer A fter C astration (2002) (0)
Risk of breast cancer (BC) relapse after 5 years of adjuvant tamoxifen (AT) in estrogen/progestrone-positive (ERP) patients (pts). (2011) (0)
Author response for "Associations of Weight Loss with Obesity‐Related Comorbidities in a Large Integrated Health System" (2021) (0)
Development and validation of a nomogram for prediction of positive systematic sextant biopsy (2002) (0)
What patients newly diagnosed with clinically localized prostate cancer need to see: an editorial dialogue. (2010) (0)
Validation of a Nomogram for Predicting a Positive Repeat Prostate Biopsy in a Multi-Specialty Group Practice Model with a Rural, Referral-Based Population (2008) (0)
Should physicians use the updated Partin tables to predict pathologic stage in patients with prostate cancer? (2007) (0)
1898: Nomograms to Predict Graft Function and Survival in Living Donor Kidney Transplantation (2007) (0)
156 Development of Nomograms to Predict Erectile Function After Radiation Therapy (2019) (0)
788: Microarray-Based Nomogram for Disease Recurrence After Radical Prostatectomy: Combining Gene Expression Information with Clinical Variables to Enhance Predictive Accuracy (2004) (0)
Editorial Comment. (2016) (0)
Prediction o f R esponse t o S alvage R adiation T herapy i n Patients W ith P rostrate C ancer R ecurrence A fter R adical Prostatectomy (2001) (0)
Original Article Predictive models for short- and long-term adverse outcomes following discharge in a contemporary population with acute coronary syndromes (2013) (0)
Author's response: Probabilistic predictions, medical decisions, and clinical usefulness (2010) (0)
PREDICTING RISK OF PROSTATE CANCER-SPECIFIC MORTALITY BASED ON CLINICOPATHOLOGIC FEATURES AT RADICAL PROSTATECTOMY (2008) (0)
328: Are the Partin Tables Accurate for African-American men in the United States? (2007) (0)
A NOMOGRAM FOR PREDICTING URETERAL STONE PASSAGE: MP01‐02 (2017) (0)
MP46-02 PROSTATE CANCER SCREENING NOMOGRAM PREDICTING 15-YEAR RISK OF CLINICALLY SIGNIFICANT PROSTATE CANCER, DEVELOPED USING COMPETING RISK ANALYSIS (2018) (0)
Guidelines for reporting observational research in urology: the importance of clear reference to causality. (2023) (0)
Renal Cell Carcinoma: A nomogram for the CT imaging-inclusive prediction of indolent, non-clear cell renal cortical tumors (2016) (0)
Urological Survey Urological Oncology : Adrenal , Renal , Ureteral and Retroperitoneal Tumors Re : ClearCode 34 : A Prognostic Risk Predictor for Localized Clear Cell Renal Cell Carcinoma (2014) (0)
Predicting risk of post-operative urinary retention in women undergoing pelvic reconstructive surgery (2018) (0)
Why should I care about statistical prediction models? (2021) (0)
1748 BLADDER CANCER PREDICTIVE NOMOGRAM FOR OVERALL SURVIVAL FOLLOWING RADICAL CYSTECTOMY (2012) (0)
GARD is a pan-cancer predictor of radiation therapy benefit (2020) (0)
Previous history of bladder cancer as a prognostic factor for patients diagnosed with transitional cell carcinoma of the upper urinary tract. (2004) (0)
MP69-07 BENEFITS AND HARMS OF DUTASTERIDE FOR PROSTATE CANCER IN THE RE-BIOPSY POPULATION FOR YEARS 1-2: A RE-ANALYSIS OF REDUCTION BY DUTASTERIDE OF PROSTATE CANCER EVENTS (REDUCE) TRIAL (2014) (0)
MP46-01 DEVELOPMENT OF PROSTATE CANCER SCREENING NOMOGRAMS FOR PREDICTING 15-YEAR RISK OF PROSTATE CANCER DIAGNOSIS AND PROSTATE CANCER MORTALITY, WITH OTHER-CAUSE MORTALITY AS COMPETING EVENT (2018) (0)
Nomogram predicting treatment-related bowel dysfunction for men with localized prostate cancer treated by radical prostatectomy (RP), external-beam radiotherapy (EBRT), and brachytherapy (PI). (2012) (0)
How should I prepare for modeling? (2021) (0)
I am going to make a prediction model. What do I need to know? (2021) (0)
1032: Is Radical Prostatectomy Performed by Trainees Associated with a Worse Outcome? (2004) (0)
PR3 RACIAL DIFFERENCES IN PREFERENCE-BASED HEALTH-RELATED QUALITY OF LIFE ASSESSMENT (2006) (0)
PCN25 CONSIDERATIONS FOR MODELING THE COST-EFFECTIVENESS OF PREVENTATIVE PROSTATE CANCER TREATMENTS (2008) (0)
Decision Making for Clinically Localized Prostate Cancer (2003) (0)
Race/ethnicity, literacy, and prostate cancer: Initial findings from the COMPARE registry. (2006) (0)
PCN76 COST-EFFECTIVENESS OF CHEMOPREVENTION WITH DUTASTERIDE BASED ON RESULTS FROM THE REDUCE CLINICAL TRIAL (2009) (0)
Development and validation of a model to predict outcomes of colon cancer surveillance (2019) (0)
DECISION ANALYSIS MODEL FOR CLINICAL STAGE I NON- SEMINOMATOUS GERM CELL TESTICULAR CANCER (2008) (0)
Things you might have expected in our book (2021) (0)
Transplant Center Performance Evaluations Are Highly Sensitive to Changes in Model Discrimination.: Abstract# B1220 (2014) (0)
855: Radical Prostatectomy (RRP) in Men >70 Years Old: Effect of Age on Upgrading, Upstaging, and Accuracy of Preoperative Nomograms (2004) (0)
Use of clinical history (CH) for Lynch syndrome (LS) risk assessment: An economic decision analysis. (2012) (0)
MP45-01 PREDICTING PROGRESSION IN PATIENTS FOLLOWED WITH ACTIVE SURVEILLANCE FOR LOW-RISK PROSTATE CANCER (2014) (0)
Should decision models drive the decision for prostate biopsy? (2011) (0)
Disposition After Total Joint Arthroplasty in the United States Wael (2010) (0)
Editorial comment. (2009) (0)
MP36-09 VALIDATION OF THE PREOPERATIVE NOMOGRAM PREDICTING 12-YEAR PROBABILITY OF METASTATIC RENAL CANCER (2018) (0)
Questioning decision analysis for treatment of clinically localized prostate cancer (1997) (0)
Can’t the computer just take care of all of this? (2021) (0)
Nomogram to predict changes in semen parameters following clomiphene citrate therapy for males with abnormal semen parameters (2022) (0)
Public Health Interventions’ Effect on Hospital Use in Patients With COVID-19: Comparative Study (2020) (0)
Propensity and Clinical Determinants of Heart Failure with Recovered Ejection Fraction: A Single-Center Longitudinal Experience (2016) (0)
1226: DERIVATION AND VALIDATION OF A BRONCHIOLITIS SEVERITY SCORE FOR THE PEDIATRIC INTENSIVE CARE UNIT (2019) (0)
Computable Phenotype of a Crohn’s Disease Natural History Model (2022) (0)
Nomograms in Prostate Cancer (2013) (0)
ADJUVANT RADIATION THERAPY FOR PATHOLOGICALLY ADVANCED PROSTATE CANCER AFTER RADICAL PROSTATECTOMY: A MULTI-INSTITUTIONAL ANALYSIS (2008) (0)
Diffusion of atitudes about questionable practices and form of moral reasoning: A social cognitive approach to global bussiness ethics: Cuadernos del Centro de Estudios Estratégicos-Primera Edición (1993) (0)
A101 Individualized Diabetes Complications Risk Scores: Future Risk of Diabetes End-Organ Complications with and without Metabolic Surgery (2019) (0)
PCN166 Comparative Effectiveness and Cost-Effectiveness of Reflex Testing Men with Intermediate PSA Levels: A Systematic Model-Based Analysis (2021) (0)
I am ready to build a prediction model (2021) (0)
What would make me an expert? (2021) (0)
Orange and Decisions-at-Hand : Bridging Medical Data Mining and Decision Support (2001) (0)
Long-term follow-up of bilateral sporadic renal tumors1 (2004) (0)
MP16-16 EFFECTIVENESS EVALUATION OF MULTI-PROPHYLACTICS STRATEGY FOR PROSTATE BIOPSY COMPARED WITH FLUOROQUINOLONE ALONE: 40,591 CASES FROM THE JAPANESE POPULATION-BASED DATABASE (2014) (0)
Quantifying Inefficiencies in Empiric Radiation Dosing: The Clinical Cost of Ignoring Biological Heterogeneity (2019) (0)
1093-P: Association between First-Line Monotherapy with Metformin and the Risk of Atrial Fibrillation in Patients with Type 2 Diabetes Mellitus (2020) (0)
Development of prostate specific antigen (PSA) screening nomograms for 15-year prediction of prostate cancer diagnosis (PCDx), mortality (PCM), and all-cause mortality (ACM) (2018) (0)
Type 1 diabetes, overweight and obesity: The overlooked epidemic (2022) (0)
7010 The role of previous abdominal surgery in the development of late rectal bleeding in prostate cancer patients treated with 3D-CRT: specific constraints and nomogram prediction (2009) (0)
A Multi-Outcome Meta-Analysis Method Reveals the Genomic Adjusted Radiation Dose is a Continuous Predictive Biomarker of Radiation Outcome (2020) (0)
PD27-11 DEVELOPMENT OF NOMOGRAMS TO PREDICT ERECTILE FUNCTION AFTER RADIATION THERAPY (2018) (0)
Development of a nomogram for predicting a positive repeat prostate biopsy (2014) (0)
Reply to Jager (2001) (0)
Development of a postoperative nomogram to predict overall survival in gastric cancer using variables the AJCC recommends for collection and registration. (2023) (0)
Editorial Comment. (2017) (0)
Prostate Cancer Screening-A New Recommendation for Meaningful Physician-Patient Conversations. (2018) (0)
Development of prostate-specific antigen (PSA) screening nomograms for 15-year prediction of prostate cancer diagnosis (PCDx), mortality (PCM), and all-cause mortality (ACM). (2018) (0)
Predicting prostate cancer behavior--what is a urologist to do? (2008) (0)
A Generalizable Competing Hazards Model of Radiation Associated Outcome Assuming Biological Heterogeneity (2019) (0)
Impact of HER2 Status on Risk of Sentinel Node Metastasis: An Independently Validated Multivariable Model. (2009) (0)
Application of Inverse-Probability-of-Treatment Weighting to Estimate the Effect of Daytime Sleepiness in Obstructive sleep apnea patients. (2022) (0)
744 NOMOGRAMS INCORPORATING SERUM C-REACTIVE PROTEIN (CRP) LEVELS EFFECTIVELY PREDICT MORTALITY AFTER NEPHRECTOMY (2013) (0)
Practical Guide to the Typical Analysis of Prognostic Factors and Biomarkers without the Use of P-Values. (2023) (0)
146 Development of a nomogram for predicting positive repeat prostate biopsy in patients with a previous negative biopsy (2012) (0)
Erratum: Prediction models for postpartum urinary and fecal incontinence in primiparous women (Female Pelvic Medicine and Reconstructive Surgery (2013) 19:2 (110-118)) (2015) (0)
Adult UrologyOncology: Prostate/Testis/Penis/UrethraEditorial Comment (2009) (0)
Introduction. (2020) (0)
197: Validation of a Nomogram for Predicting a Repeat Positive Prostate Biopsy in a Ruralinonurban Setting (2006) (0)
639: Predictors of Prostate Cancer Detection Using an Extended Biopsy Regimen in Patients with a Total PSA Between 2.5 and 4.0NG/ML (2004) (0)
The log-beta Weibull regression model with application to predict recurrence of prostate cancer (2011) (0)
2214 : Postoperative Nomogram Predicting the 9-Year Probability of Prostate Cancer Recurrence After Permanent Prostate Brachytherapy (2006) (0)
Impact of neoadjuvant therapy on histopathologic response and survival in patients with primary high-grade retroperitoneal soft tissue sarcomas (2008) (0)
A Nomogram for Prediction of Survival for Patients Undergoing Elective Major Noncardiac Surgery (2009) (0)
A first step towards a global nomogram to predict disease progression for men on active surveillance (2020) (0)
Chapter 24 – The Decision-making Process for Prostate Cancer (2003) (0)
V14-10 MRI/US FUSION GUIDED PROSTATE BIOPSY AND CRYOTHERAPY IN A CLINICAL OFFICE SETTING (2021) (0)
Prostate Cancer in Lymph Nodes Transcription-PCR for the Detection of Micrometastatic Comparison of Immunohistochemistry with Reverse Updated Version (2003) (0)
476 COMPARISON OF OBSERVED PROSTATE CANCER-SPECIFIC MORTALITY (PCSM) BY TREATMENT-SPECIFIC, NOMOGRAM-PREDICTED RISKS OF BIOCHEMICAL RECURRENCE (BCR) IN MEN WITH LOCALIZED PROSTATE CANCER TREATED BY RADICAL PROSTATECTOMY (RP), EXTERNAL BEAM RADIOTHERAPY (EBRT), OR BRACHYTHERAPY (PI) (2011) (0)
Development and validation of a pretreatment nomogram to predict disease-specific mortality in gastric cancer. (2020) (0)
Incidence of reduced penis size among men with recurrent prostate cancer previously treated with surgery, radiation plus androgen deprivation, or radiation alone. (2012) (0)
A first step towards a global nomogram to predict disease progression for men on active surveillance (2020) (0)
Editorial Comment. (2016) (0)
Seminar article The prediction philosophy in statistics (2008) (0)
Detection o f C linically S ignificant, O ccult P rostate C ancer Metastases i n L ymph N odes U sing a S plice V ariant-Specific RT-PCR A ssay f or H uman G landular K allikrein (2003) (0)
Validation of nomograms predicting semen parameters following varicocele repair (2014) (0)
MP44-11 DEVELOPMENT OF A PREDICTIVE NOMOGRAM FOR CHANGES IN SEMEN PARAMETERS FOLLOWING CLOMIPHENE CITRATE THERAPY (2020) (0)
Nomograms to predict five-year freedom from relapse and overall survival after surgery for endometrial cancer (2010) (0)
THE HOSPITAL READMISSION MODEL POORLY PREDICTS 30-DAY REHOSPITALIZATION IN HEART FAILURE (2017) (0)
1763: Multicenter Analysis of Outcomes in Patients Treated with Permanent Prostate Brachytherapy: Effect of PSA Failure Definition and Dose on Biochemical Defined Relapse (2007) (0)
Nomograms for Prostate Cancer Decision Making (2015) (0)
Nomogram development and validation (2017) (0)
The Predictive Power of Prostate Cancer Extent Measurements in a Large Watchful Waiting Cohort (2009) (0)
1250: Pre-Surgical Nomogram Predicting 12-Year Probability of Metastatic Recurrence Following Nephrectomy for Renal Masses (2007) (0)
Abstract 20782: Incidence and Predictors of Postoperative Atrial Fibrillation in Patients Undergoing Elective Noncardiac Surgery in a large cohort of patients (2010) (0)
Pretreatment N omogram T hat P redicts 5 -Year P robability o f Metastasis F ollowing T hree-Dimensiona l C onformal R adiation Therapy f or L ocalized P rostate C ancer (2003) (0)
Subject Index Vol. 1, 2007 (2008) (0)
A NOMOGRAM FOR PREDICTING SIGNIFICANCE UPGRADING IN PATIENTS WITH LOW AND INTERMEDIATE GRADE PROSTATE CANCER IN THE ERA OF EXTENDING PROSTATE SAMPLING (2009) (0)
Prostate cancer: Does genetic score justify early prostate biopsy? (2013) (0)
Nomograms play growing role in Pca outcomes (2004) (0)
Comprehensive comparison of health-related quality of life after radical prostatectomy, high- dose intensity modulated radiotherapy and intraoperative conformal brachytherapy for localized prostate cancer (2002) (0)
Title: Derivation and validation of a machine learning risk score using biomarker and electronic patient data to predict rapid progression of diabetic kidney disease (2020) (0)
Preoperative P lasma L evels o f T ransforming G rowth F actor Beta 1 (TGF- b 1 ) S trongly P redict P rogression i n P atients Undergoing R adical P rostatectomy (2001) (0)
Prognostic M odel f or P redicting S urvival i n M en W ith Hormone-Refracto ry M etastatic P rostate C ancer (2003) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Michael W Kattan?

Michael W Kattan is affiliated with the following schools:

Indiana University Bloomington
Indiana University
University of Oxford
University of Michigan
University of Houston
Baylor College of Medicine
Case Western Reserve University
University of Toronto
University of São Paulo
Massachusetts General Hospital
Leiden University
University of Arkansas

Michael W Kattan's Academic­Influence.com Rankings

Why Is Michael W Kattan Influential?

Michael W Kattan's Published Works

Published Works

What Schools Are Affiliated With Michael W Kattan?

Michael W Kattan's AcademicInfluence.com Rankings